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ABSTRACT OF THE DISSERTATION
FOOD INSECURITY IS ASSOCIATED WITH NONALCOHOLIC FATTY LIVER
DISEASE, COGNITIVE IMPAIRMENT, AND IMMUNE ACTIVATION IN PEOPLE
LIVING WITH HIV
by
Javier A. Tamargo
Florida International University, 2021
Miami, Florida
Professor Adriana Campa, Co-Major Professor
Professor Marianna K. Baum, Co-Major Professor
Food insecurity (FI) is a socioeconomic condition characterized by inadequate
access to enough food and nutrition to sustain health and wellbeing. Food insecurity is a
risk factor for chronic and age-related conditions, raising concerns for the aging
population of people living with HIV (PLWH), in whom food insecurity is
disproportionately prevalent. PLWH are at increased risk of nutrition-related
complications and chronic co-morbidities, thus food insecurity may exacerbate adverse
health outcomes in this population. This study investigated whether food insecurity was
associated with nonalcoholic fatty liver disease (NAFLD), cognitive impairment, and
immune activation among socioeconomically disadvantaged adults living with and
without HIV.
This study was conducted with participants from the Miami Adult Studies on HIV
(MASH) Cohort, predominantly comprised of low-income Black and Hispanic middleaged adults. Food insecurity was measured with the U.S. Household Food Security
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Survey. Magnetic resonance technology was used to assess liver steatosis and fibrosis.
The Mini-Mental State Examination was used to assess cognitive impairment.
Biomarkers of monocyte/macrophage (sCD14 and sCD163) and lymphocyte (sCD27)
activation were measured from blood samples.
Approximately a third of participants experienced food insecurity. Food insecurity
modified the effect of BMI on NAFLD, increasing the risk associated with increasing
BMI among those who experienced food insecurity. Additionally, food insecurity was
independently associated with increased risk for any and advanced liver fibrosis. Baseline
food insecurity and its frequency over a 2-year period were associated with cognitive
decline, particularly when food insecurity was persistent. The effects of food insecurity
on liver disease or cognitive impairment were not significantly different between PLWH
and HIV-uninfected participants. Among PLWH, food insecurity was associated with
increased sCD14 and sCD27, which also correlated with the severity of food insecurity.
The severity of food insecurity also appeared to moderate the relationship between CD4
cell count and sCD163.
Food insecurity may contribute to the NAFLD and cognitive decline among lowincome U.S. minorities. Although food insecurity did not have greater effects for PLWH
compared to those HIV-uninfected, food insecurity may promote immune activation in
PLWH, suggesting a biological link between food insecurity and adverse health
outcomes. Improving financial security and access to high-quality foods could reduce the
high burden of disease in vulnerable populations.
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CHAPTER I: INTRODUCTION
Statement of Problem
Over 1.2 million adolescents and adults in the United States (U.S.) are living with
the human immunodeficiency virus (HIV).1 People living with HIV (PLWH) are, in its
majority, a marginalized group disproportionately affected by socioeconomic hardships
and stigma.2,3 In the United States, HIV infections are mostly concentrated in poor
communities, where racial-ethnic minorities − particularly Black Americans − are overrepresented.2 As a result of social disparities, PLWH are disproportionately affected by
food insecurity,4-6 a socioeconomic condition of inadequate access to sufficient, safe, and
nutritious foods to sustain health and wellbeing. Although population-wide studies are
needed, 40-60% prevalence of food insecurity among PWLH in the United States have
been reported,7-10 making it approximately four to six times greater than in the general
U.S. population.5
Advances in antiretroviral therapy (ART) have improved HIV-related health
outcomes and made it possible for PLWH to live longer lives, achieving lifespans that are
similar to those of the general population.11-13 As a result, the prevalence of HIV
infections in the United States continues to rise although the incidence rate has
declined.14 As PLWH live longer, chronic and age-related conditions have become the
predominant causes of morbidity and mortality, impacting their health and quality of
life.15-20 Indeed, PLWH are at increased risk for many chronic, non-communicable
diseases,19,21-23 and have higher rates of multi-morbidity.20,24,25
Food insecurity raises particular concerns for PLWH. On one hand, food insecurity
is associated with poorer adherence to ART,26,27 lower odds for viral suppression,28 and
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lower CD4 cell counts.29 Thus, food insecurity promotes immunodeficiency and HIV
disease progression, increasing the risk for mortality.4,30 By contributing to poor HIV
control, food insecurity may be a barrier for the eradication of HIV. On the other hand,
food insecurity also increases the risk for compromised nutritional status (e.g.
malnutrition, micronutrient deficiencies)6,31 and the development and/or progression of
comorbidities.8,9,32-39 There are several nutrition-related complications in HIV infection,
such as increased nutritional and metabolic demands,40,41 as well as altered
gastrointestinal function resulting in decreased food intake and poor absorption of
nutrients.42-45 Both HIV infection and ART can lead to metabolic abnormalities and
increase the risk for cardiometabolic conditions.46,47 Given the high rates of food
insecurity among PLWH, their susceptibility and vulnerability to chronic diseases, and
the associations of food insecurity with poor health outcomes, food insecurity may
significantly contribute to the burden of disease among U.S. adults living with HIV.
While several studies have explored the associations between food insecurity and
chronic diseases in the general U.S. population,34-38,48,49 relatively fewer studies have
done so specifically in PLWH.8,9,32,33 In particular, two emerging health concerns have
garnered recognition in recent years. Nonalcoholic fatty liver disease (NAFLD) has
become the most prevalent liver disease in the world, with a rise in prevalence that
parallels that of obesity, type 2 diabetes (T2D), and metabolic syndrome (MetS).50 While
precise estimates are needed, the rate of NAFLD tends to be higher in PLWH than in the
general population51 and PLWH have almost twice the rate of nonalcoholic
steatohepatitis (NASH)52 − a more progressed stage of the disease. In fact, liver disease is
a leading cause of morbidity and mortality among PLWH,53 and it has been associated
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with cognitive impairments in PLWH even in the absence of viral hepatitis.54-56 Despite
advances in treatments, cognitive dysfunctions continue to affect a significant portion of
PLWH.57-64 Indeed, HIV-associated dementia is now relatively rare with 2-4%
prevalence, but milder neurocognitive disorders are found in approximately 20-50% of
PLWH63 and persist despite long-term viral suppression.62 Regardless of a growing
interest in these conditions, few studies have examined their associations with food
insecurity, particularly among PLWH.
Persistent inflammation and immune activation are considered key factors in HIV
disease progression and are implicated in chronic conditions in PLWH.65-68 Activation of
the immune system refers to the immune response to invading pathogens.69 More
specifically, immunologic activation is the process by which immune cells are stimulated,
triggering specific immune defenses. While these systems are beneficial in the short term,
chronic activation of immune systems can be deleterious.69 Indeed, chronic inflammation
and immune activation have been reported in association to liver disease70-72 and
cognitive disorders73-75 in PLWH. Food insecurity has been associated with proinflammatory diets and inflammation,76-79 suggesting a biological pathway between food
insecurity and chronic diseases. However, few studies to date have directly examined
whether food insecurity contributes to immune activation in PLWH. In particular, food
insecurity, and the poor-quality diets associated with it, could contribute to gut
permeability and the translocation of pathogens and other toxic microbial products
through the intestinal epithelial barrier (known as microbial translocation)80 − a
significant source of immune activation in PLWH.81
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Significance of Study
The issues examined in this study have implications that expand from the local
community to the globe. Food insecurity affects all levels of society − global, regional,
national, community, household, and individual.82 This study was conducted in MiamiDade County, which has one of the highest rates of HIV infections in the United States.83
Yet, there are currently 37.9 million people in the world living with HIV, most of whom
live in countries where food insecurity and undernutrition are endemic.84 Globally, an
estimated 26% of the world population (approximately 2 billion people) experienced
moderate-to-severe food insecurity in 2019 and 8.9% were undernourished.82
NAFLD, paralleling obesity, has reached pandemic proportions85 and its global
prevalence has been estimated at approximately 25%.86 NAFLD is associated with
increased risk for morbidity and mortality, particularly at the more advanced stages of the
disease.87 Still, some have argued that NAFLD remains underappreciated and
understudied among PLWH.88
Furthermore, an estimated 16% (12-20%) of older adults have mild cognitive
impairment and 34% (27-40%) progress to dementia.89 Cognitive impairments and
dementia are seen in approximately 18-21% and 5-8%, respectively, of older adults in the
United States.90,91 Nutritional risk factors such as food insecurity, malnutrition, and
obesity can contribute to cognitive impairments. Both food insecurity8 and obesity92 are
prevalent among PLWH, and food insecurity has been associated with both malnutrition
and obesity in PLWH.6,93 Also, food insecurity94 and obesity95,96 have been identified as
risk factors for cognitive impairments in PLWH, while underweight is associated with
progression of mild cognitive impairment to dementia in the elderly.97 Others have
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reported associations between decreased cognitive function and central or abdominal
obesity.98-100 Additionally, obesity is tightly associated with fatty liver and is a risk factor
for progression of liver disease to cirrhosis,101 further contributing to the risk of cognitive
impairment.
Innovation
At the time of this writing, only one study has evaluated the relationship between
food insecurity and liver disease, conducted with data from the National Health and
Nutrition Examination Survey (NHANES).102 However, the investigators used indirect
measures of hepatic steatosis and fibrosis with poor sensitivity. In this study, we used
magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) to quantify
liver fat content and magnetic resonance elastography (MRE) to assess liver stiffness, a
measure of fibrosis. These measures are non-invasive and highly accurate,103,104
providing an innovative approach to investigate the problem. Additionally, no studies to
date have examined the link between food insecurity and liver disease among PLWH. In
the Miami Adult Studies on HIV (MASH) cohort, 98% of participants living with HIV
report taking ART and over 80% are virally suppressed (viral load <200 copies/mL). This
is similar to other cohorts of PLWH in care,105 but markedly higher than in the general
United States (57%).106 The MASH cohort, therefore, presents a rare opportunity to
examine health outcomes among free-living PLWH who are engaged in care and virally
suppressed, but are at increased risk for food insecurity and comorbidities.
Moreover, food insecurity has an inverse correlation with cognitive function,107 but
only two cross-sectional studies have examined this association in PLWH with
conflicting results.94,108 Yet, for many households, food insecurity is a frequent or

5

persistent problem that occurs for an average of 7 months out of the year.109 However, no
studies to date have examined the longitudinal relationship between food insecurity and
cognitive impairment among people living with HIV, while considering the impact of the
frequency of food insecurity over time.
Lastly, to the best of our knowledge, only one study previously examined whether
food insecurity is associated with immune activation in PLWH − as measured by plasma
levels of CD4+ and CD8+ T-cell %CD38+HLADR+.110 Immune activation is thought to
contribute to non-AIDS co-morbidities in PLWH.65 Previous studies have associated food
insecurity with markers of chronic inflammation.76,77,79 Therefore, immune activation
may be a potential biological pathway between food insecurity and the high burden of
comorbidities in this population. Indeed, persistent immune activation has been
implicated in liver disease70,72 and neurocognitive disorders73,75 among PLWH.
Altogether, the results of this study serve to improve public health by improving
our knowledge regarding major public health concerns of local, national, and global
relevance, with implications for clinical settings and policymakers. The following aims
and hypotheses are presented as three distinct chapters, each written as a research article.
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Specific Aims and Hypotheses
Chapter III: Association of Food Insecurity with Nonalcoholic Fatty Liver Disease
Specific Aim 1: To determine whether food insecurity is associated with NAFLD using
accurate, non-invasive magnetic resonance (MR) technology.
Hypothesis 1a: Food insecurity (assessed with the U.S. Household Food Security
Survey) will be associated with increased risk for NAFLD (liver fat >5%) as
determined by MRI-PDFF.
Hypothesis 1b: Food insecurity will be associated with increased risk for liver
fibrosis as determined by MRE.
Hypothesis 1c: The effects of food insecurity on liver outcomes will be significantly
higher in PLWH than HIV-uninfected participants.
Chapter IV: Association of Food Insecurity with Cognitive Impairment
Specific Aim 2: To determine whether food insecurity is associated with cognitive
impairment cross-sectionally and after a 2-year follow-up.
Hypothesis 2a: Food insecurity will be independently associated with increased risk
for cognitive impairment as determined by the Mini-Mental State Examination
(MMSE).
Hypothesis 2b: The risk for cognitive impairment will correlate with the frequency of
food insecurity.
Hypothesis 2c: The effect of food insecurity on cognitive impairment will be stronger
for PLWH than HIV-uninfected participants.

7

Chapter V: Association of Food Insecurity with Immune Activation in PLWH
Specific Aim 3: To determine whether food insecurity is associated with increased
immune activation in PLWH.
Hypothesis 3a: Food insecurity will be associated with increased immune activation
in PLWH as determined by plasma levels of sCD14, sCD27, and sCD163.
Hypothesis 3b: The severity of food insecurity will correlate with levels of sCD14,
sCD27, and sCD163.
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Table 1.1. Summary of Hypotheses and Methods
Dependent
Hypothesis Variable(s)
1a
Food insecurity

Measurement of Dependent
Variable(s)
HFSS

1b

HFSS

Food insecurity

Independent
Variable(s)
NAFLD

Measurement of Independent
Variable(s)
MRI-PDFF
(liver fat >5%)
MRE
LS ≥2.9 kPa ≥ stage 1
LS ≥3.8 kPa ≥ stage 3
MRI-PDFF
MRE

Statistical Plan
Chi-square test
Logistic regression
Chi-square tests
Logistic regressions

Liver fibrosis
Advanced
fibrosis
1c
Food insecurity
HFSS
NAFLD
Logistic regressions with
HIV
Medical records
Liver fibrosis
FI*HIV interaction term
Advanced
fibrosis
2a
Baseline food
HFSS
Cognitive
MMSE (≤ 24) at baseline and Chi-square test
insecurity
impairment
at 2-year follow-up
Logistic regressions
2b
Frequency of food HFSS, measured at baseline and 12- Cognitive
MMSE (≤ 24)
Logistic regression
insecurity
and 24-month follow-ups
impairment
2c
Food insecurity
HFSS
Cognitive
MMSE (≤ 24)
Logistic regression with
HIV
Medical records
impairment
FI*HIV interaction term
3a
Food insecurity
HFSS
Immune
Plasma sCD14, sCD27,
Linear regressions
activation
sCD163
3b
Severity of food
HFSS
Immune
Plasma sCD14, sCD27,
Spearman correlation
insecurity
activation
sCD163
Linear regressions
Abbreviations: FI, food insecurity; HFSS, U.S. Household Food Security Survey; LS, liver stiffness; MMSE, Mini-Mental State Examination; MRE,
magnetic resonance elastography; MRI-PDFF, magnetic resonance imaging-derived proton density fat fraction
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CHAPTER II: LITERATURE REVIEW
Food Insecurity in the United States
Food insecurity refers to a lack of adequate access to sufficient, safe, and nutritious
foods to sustain health and wellbeing. More specifically, food insecurity is characterized
by an uncertain ability or inability to procure enough food to feel satiated and live a
healthy life.1 Distinct from hunger, a physiological condition that occurs solely at the
individual level,2 food insecurity is a socioeconomic condition that can be measured at all
levels of society − global, regional, national, community, household, and individual.3 The
Food and Agriculture Organization (FAO) of the United Nations identifies four key
dimensions of food insecurity: 1) local availability of foods through adequate food
systems; 2) whether households or individuals have access to those foods; 3) utilization
of foods for optimal nutrition; and 4) temporal stability of the previous conditions.3
Importantly, food insecurity in the United States is conceptualized somewhat differently
from countries with fewer resources.4 In the United States and similar high-resource
countries, calories are inexpensive and readily accessible, but adequate nutrition may be
inaccessible both financially and physically.5
In the United States, an estimated 10.5% of households, or 13.7 million households,
experienced food insecurity at some point in 2019, including 2.4 million households with
children.6 Unfortunately, recent rates of food insecurity in the United States are not
dissimilar from those seen over two decades ago,6 although the spike caused by the Great
Recession has leveled out.7 Moreover, the national state of food security is highly volatile
and may be precipitated by national crises. In the wake of the novel coronavirus disease
of 2019 (COVID-19) pandemic, subsequent to a dramatic rise in unemployment and food
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systems affected leading to food shortages, the national rate of food insecurity rose to an
estimated 38.3%.8 Food insecurity is a consequence of limited resources and is associated
with poverty, unemployment, and high housing costs.9 Indeed, the rate of food insecurity
is 35% among households with incomes below the federal poverty level compared to 5%
in those with incomes above 185% of poverty.6 Racial/ethnic minorities are particularly
affected, with rates above the national average seen in Black non-Hispanic (19.1%) and
Hispanic (15.6%) households.6 In the midst of the COVID-19 pandemic, minorities were
disproportionately affected by economic stressors, leading to nearly twice the odds of
food insecurity in Blacks and Native Americans compared to Whites, and 30% higher
risk among Hispanics compared to non-Hispanics.8
Food insecurity can be a chronic or transitory problem. In the United States, food
insecurity is often episodic and recurrent, triggered by unemployment, inflation, food
prices, and unforeseen costs.10,11 Nonetheless, for many households, food insecurity is a
frequent or persistent problem experienced for an average of 7 months out of the year.12,13
About 56% of food-insecure U.S. households in 2018 participated in federal food
assistance programs,14 but these are often insufficient to relieve financial constraints.4,15,16
Moreover, the reliance on food assistance leads to fluctuations in food intake, or a “food
stamp cycle,” in which food spending and, subsequently, food intake peak early in the
month and sharply decrease towards the end of the month.17,18
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Assessment of Food Insecurity
Several tools have been developed to measure the various aspects of food
insecurity at different social levels.19 The most widely utilized and well-validated
instrument has been the U.S. Household Food Security Survey (HFSS).6 The HFSS has
been validated across U.S. demographics20,21 and has been adapted for use in other
settings with favorable results.19,22 The 18-item questionnaire assesses a respondent’s
perceived food sufficiency and adequacy, food-related anxiety, and instances of hunger
that occurred in the household during the past 12 months.23 While the HFSS was
designed to measure food insecurity at the household level, it has also been validated to
measure food insecurity at the individual level.20
The HFSS can categorize households into four levels food security, or by
increasing severity of food insecurity: high (or full), marginal, low, and very low food
security (VLFS). Recent research has demonstrated that the severity of food insecurity
seems to influence its association with health outcomes.24-27 Important distinctions can be
observed between households reporting no food insecurity (full food security) and those
with one or two food-insecure conditions (marginal food security), although these two
categories would be typically considered food-secure. In fact, the demographic
characteristics of marginally food-secure households more closely resemble those of
food-insecure households than those with full food security.28 The same is true for
households that would otherwise be categorized as food-insecure, which typically
combines low and very low food security. Low food security (previously known as “food
insecurity without hunger”) is defined as reduced quality, variety, or desirability of diet,
with little or no indication of reduced food intake.29 Very low food security, previously
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known as “food insecurity with hunger,” is characterized by multiple indications of
disrupted eating patterns and reduced food intake.6,29 Recently, Choi et al. identified
several distinguishing characteristics of households with VLFS.16 Depending on whether
the households had children, older adults, or neither, VLFS households could be
identified by increased or decreased participation in food assistance programs, as well as
health status and access to healthcare, such as unmet medical care needs, poor health,
disability, and depression.16
Food Insecurity: A Social Determinant of Health
Food insecurity is a risk factor for poor health outcomes at all ages,4,30-32 making it
an important social determinant of health.33,34 In effect, adults from food-insecure
households are at increased risk for chronic cardiometabolic diseases and mental health
problems.24,30,31,35-38 Many factors may contribute to the associations between food
insecurity and poor health outcomes, including poor diet quality,39 increased stress,40,41
poor adherence to medical recommendations,42 and misuse of alcohol and other
substances.43-48 Food insecurity may lead to inadequate dietary intakes, poor diet quality,
and disrupted eating patterns that result in suboptimal nutritional status.49-51 In fact, food
insecurity is a predictor of poor diet quality and compromised nutritional status among
U.S. adults even after accounting for the effect of poverty.52 Poor quality diets associated
with food insecurity can result in inadequate intake of key nutrients and nutritional
deficiencies, as well as increased risk for morbidity and mortality.9,53,54
On the other hand, food insecurity may contribute to chronic disease through its
paradoxical association with obesity.55 Indeed, in the United States, energy intakes do not
seem to be altered by food insecurity; rather, the differences in health outcomes seem to
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stem from dietary habits and the quality of the diet. Zizza et al. reported that individuals
who experienced food insecurity consumed fewer but larger meals and snacked on sweets
more frequently than those who were food-secure, yet energy intakes did not differ.56
Individuals from households with low food security, compared to those with full food
security, tend to shop more frequently at convenience/dollar stores, which carry limited
choices and fewer fresh foods (e.g. fruits and vegetables) than grocery stores and
supermarkets.57 The differences in food shopping behaviors are often related to
difficulties in transportation.57 Food insecurity is also associated with poor food literacy,
thus food labels and other nutritional information material may not be effective in
improving food choices among food-insecure individuals.50
Furthermore, food-insecure households are often forced to make tradeoffs between
buying food or paying for other necessities, such as medical care and medications.58,59 At
the same time, food insecurity is associated with increased healthcare utilization and
higher health care expenditures.60-62
Food Insecurity Among People Living with HIV
People living with HIV (PLWH) are disproportionately affected by food insecurity
in both resource-poor and resource-rich settings.63 This is also seen in the United
States,64-66 where the prevalence of HIV in poor urban areas is similar to those seen in
low-income countries with HIV epidemics.67 Many PLWH in the United States are
unemployed or disabled,67-69 contributing to financial instability and food insecurity.
Likewise, food insecurity is associated with a higher prevalence of HIV. A study using
1999-2012 NHANES data showed that men from food-insecure households were twice as

25

likely to be infected with HIV than those from food-secure households.70 Further, women
living with HIV are at higher risk for food insecurity than men living with HIV.71
To be sure, food insecurity and HIV have a complex, multifaceted, and
bidirectional relationship. Food insecurity can increase the risk for HIV infections and
disease progression (usually measured as a rise in HIV-RNA copies and a decline in CD4
cell counts), and in turn, HIV contributes to and reinforces food insecurity.63,72 Frega et
al. described how food insecurity and HIV are interconnected at the community,
household, and individual levels.72 Weiser et al. described nutritional, mental health, and
behavioral pathways for the effect of food insecurity on HIV and vice versa.63 The
bidirectional relationship between food insecurity and HIV is illustrated in Figure 2.1 and
summarized below. Importantly, mental health, comorbidities, and HIV-related morbidity
and mortality are at the intersection of food insecurity and HIV.
Food insecurity is thought to contribute to HIV transmissions through its
association to financial stress and living conditions that lead to negative and unsafe
coping behaviors, such as risky sexual practices (e.g. bartering sex for money or food)73,74
and substance use, particularly injection drug use and needle-sharing.47,75,76 At the
individual level, food insecurity can promote immunodeficiency by compromising
nutritional status (e.g. malnutrition, nutrient deficiencies),39,77,78 thereby increasing
vulnerability to HIV infection.79 Furthermore, food insecurity may increase the risk for
HIV transmissions by making PLWH more infectious. Indeed, food insecurity is strongly
associated with poor adherence to treatment,73,80 lower odds for viral suppression,81 and
lower CD4 cell counts.82
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Figure 2.1. Bidirectional Relationship Between Food Insecurity and HIV
* The contribution of food insecurity to liver disease and cognitive impairment among PLWH are
hypothesized in this dissertation.

HIV infection leads to incremental metabolic demands as the disease
progresses,83,84 thus food insecurity may further compromise nutritional status in PLWH.
Food insecurity can also contribute to non-AIDS-related co-morbidities,32,85 adding to the
burden of morbidity and mortality in PLWH.86 Thus, food insecurity can promote
immunodeficiency, HIV disease progression, and increase overall disease burden,
ultimately lowering health-related quality of life87 and increasing mortality among
PLWH. Given all of this, food insecurity may also be a barrier for the eradication of HIV.
On the other hand, HIV may promote food insecurity by impacting the availability,
access, and utilization of food.72 A high prevalence of HIV in a community may decrease
food availability by affecting overall productivity and increasing morbidity and mortality;
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however, more evidence is needed to ascertain this link. At the household level, HIVrelated morbidity and mortality leads to losses in productivity and increased financial
burdens that may affect access to food. At the individual level, HIV alters appetite,
gastrointestinal function, energy expenditure, and metabolism, ultimately increasing
nutritional demands which then may precipitate or exacerbate food insecurity. These
HIV-related complications also promote morbidity and mortality among PLWH, which
then may contribute to food insecurity at the community and household levels.63,72
Nonalcoholic Fatty Liver Disease
Chronic liver disease is a significant cause of morbidity and mortality worldwide.
Liver cirrhosis accounts for more than 2.4% (1.3 million) of annual deaths worldwide.88
Liver cancers account for 8.2% (781,631) of all cancer-related deaths globally, the
majority of those (75-85%) being hepatocellular carcinoma (HCC).89 In the United
States, close to 2% of U.S. adults, or 4.5 million, were diagnosed with a chronic liver
disease in 2018, a leading cause of mortality among U.S. adults 25 years of age and
older.90 Furthermore, annual deaths in the United States due to liver cirrhosis and HCC
increased by 65% and 217%, respectively, from 1999 to 2016.91 In Western countries,
alcohol-associated liver disease and nonalcoholic fatty liver disease (NAFLD), rather
than hepatitis viruses, are now the predominant causes of liver-related morbidity and
mortality.92 This is largely due to the availability of hepatitis B virus (HBV) vaccines and
effective antiviral treatments for HBV and hepatitis C virus (HCV).93 What is worse, the
burden of fatty liver diseases is expected to rise.94-99
Nonalcoholic fatty liver disease (NAFLD) is an increasing public health concern
that has paralleled the rising rates of obesity and other metabolic conditions, particularly
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MetS − a cluster of conditions which may include abdominal obesity, hyperlipidemia,
hypertension, and hyperglycemia.100 In fact, NAFLD has emerged as the most common
liver disease in the United States and other Western countries.98,101-103 NAFLD is
characterized by (1) evidence of hepatic steatosis (≥5% liver fat) and (2) absence of
secondary causes for hepatic fat accumulation such as significant alcohol consumption
(>21 drinks/week in men and >14 drinks/week in women), use of steatogenic medication,
or hereditary disorders.104 The pathological spectrum of NAFLD encompasses
nonalcoholic fatty liver (NAFL; or simple steatosis), nonalcoholic steatohepatitis
(NASH), cirrhosis, and HCC. In addition to liver steatosis, NASH is characterized by the
presence of inflammation and hepatocyte injury with or without fibrosis.104 Liver fibrosis
(scar tissue) occurs as a consequence of necroinflammation and liver cell injury and may
progress to cirrhosis and HCC.
Worldwide, the prevalence of NAFLD has been estimated at approximately
25%.105 NAFLD is present in both high- and low-resource countries, but in the United
States, the estimated prevalence is close to a third of all adults.106,107 This rate is in stark
contrast to an estimated prevalence of 18% in 1988–1991.107 Among individuals with
NAFLD, there is an estimated NASH prevalence of 30%108 and a 22.8% prevalence of
advanced fibrosis.106 The prevalence of NASH-cirrhosis has increased two and a half
times between 1999-2002 and 2009-2012.109 Moreover, the prevalence of NAFL and
NASH are expected to rise by 21% and 63%, respectively, by the year 2030.96
Subsequently, there will be a higher burden of cirrhosis and HCC.96 Despite the high
prevalence of NAFLD, only about 5% of all individuals with NAFLD in the United
States seem to be aware of their condition.106

29

Recently, an International Consensus Panel proposed to replace the nomenclature
of NAFLD to metabolic (dysfunction)-associated fatty liver disease (MAFLD) as it more
closely reflects its pathological features and our growing understanding of fatty liver
disease.110 Instead of defining NAFLD for what it is not (i.e. “nonalcoholic”, viral
hepatitis, autoimmune), MAFLD identifies the disease from the underlying pathological
processes. Nonetheless, others have urged for caution as the change in nomenclature
might be premature.111 In light of a lack of consensus and the near ubiquitous use of
“NAFLD/NASH” in the literature, the traditional nomenclature will be used throughout
this text.
NAFLD in People Living with HIV
People living with HIV are especially vulnerable to liver diseases.112 Historically,
PLWH have been vulnerable to coinfection with HBV and HCV,113 as well as alcoholrelated liver disease due to a high prevalence of alcohol use disorder.114,115 Yet, as viral
hepatitis infections are increasingly treated, the burden of fatty liver disease among
PLWH has gained recognition.116 A meta-analysis of imaging studies showed a 35%
prevalence of NAFLD among PLWH, with biopsy studies showing NASH in 42% and
fibrosis in 22%.117 These estimates suggest that PLWH have a higher prevalence rate of
NAFLD/NASH than the general population. Furthermore, PLWH are more susceptible to
liver-related complications since HIV accelerates liver disease progression.112
Assessment of NAFLD
Liver biopsy has been the cornerstone of diagnosis, assessment of prognosis, and
therapeutic decision-making for liver diseases.118 However, liver biopsy is an invasive
procedure that is costly and fraught with contraindications and potential health
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complications.118 Furthermore, only 1/50,000th of the liver is sampled with biopsy,119
adding concerns of sampling error. For these reasons, several non-invasive tests have
been developed, which in general are more time- and cost-efficient, allowing for repeated
assessments and monitoring of liver disease progression.120,121 These non-invasive
assessments include biological and imaging assessments (Table 2.1). Nonetheless, most
of these assessments are insufficiently sensitive or specific,122,123 and frequently used
cutoffs may not be appropriate for all age and ethnic groups.124,125
Magnetic resonance imaging (MRI)-based assessments have emerged as highly
accurate, but direct, non-invasive measures of liver steatosis and fibrosis.126-131 Chemical
shift encoded MRI methods can differentiate protons in water and triglycerides.132 By
quantifying the signals arising from water and fat in tissues, the proton density fat
fraction can be calculated (PDFF) − defined as “the ratio of the density of mobile protons
from triglycerides and the total density of protons from mobile triglycerides and mobile
water” − and expressed as percentages.132 Thus, liver steatosis can be assessed with MRIPDFF, which demonstrates high correlation with liver steatosis grade and NAFLD
activity score when compared with histologic assessment.133 However, histologic
assessment remains the only available technique to differentiate NASH from simple
steatosis.134 Magnetic resonance elastography (MRE) combines MRI with low-frequency
shear waves (vibrations), the speed of which is dependent on the stiffness of tissues, to
create an elastogram that can be used to quantify tissue stiffness through an inversion
algorithm.135 Liver stiffness measurement by MRE is considered the most accurate
noninvasive assessment of liver fibrosis, with sensitivity and specificity nearly equal to
histological assessment.126
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Natural History of NAFLD
The natural course of NAFLD is a highly dynamic process that has not been fully
elucidated. The prevalence of NAFLD is highly associated with metabolic conditions,
primarily obesity, type 2 diabetes, and the metabolic syndrome.104 In fact, historically,
NAFLD has been generally considered the liver manifestation of metabolic syndrome.136
However, new lines of evidence have shown NAFLD as both the cause and consequence
of these metabolic conditions. For example, NAFLD has been associated with incident
type 2 diabetes and metabolic syndrome,137,138 which are then predictors of NASH and
fibrosis progression.139,140 Thus, the relationship between NAFLD and metabolic
syndrome is better described as mutual and bidirectional. In addition to metabolic risk
factors, age, male sex, and Hispanic ethnicity are risk factors (or risk modifiers) for
NAFLD.141 Genetic variations also play an important role in NAFLD risk and disease
progression. In particular, the rs738409 variant in human patatin‐like phospholipase
domain containing 3 gene (PNPLA3) for adiponutrin has been extensively studied.142
The course of NAFLD is nonlinear and only a portion of NAFLD patients progress
to advanced stages of liver disease. Initially, a meta-analysis of 11 paired-biopsy studies
by Singh et al. suggested that NASH was associated with twice as rapid fibrosis
progression compared to NAFL.143 Among 411 NAFLD patients, a total of 33.6% had
progressive fibrosis (a 1-stage progression of fibrosis), while 43.1% remained stable and
22.3% showed improvements. The fibrosis progression rates among patients with NAFL
and NASH were 7.1 (95% CI 4.8–14.3) and 14.3 (9.1–50.0) years per stage, respectively.
Furthermore, Singh et al. identified a subset of “rapid progressors;” 21% of NAFLD
patients without fibrosis at baseline who progressed to advanced fibrosis (stage 3 or 4
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fibrosis) over 5.9±3.7 years. However, NASH has repeatedly failed to predict fibrosis
progression,139,144,145 possibly due to NASH not being a stable, fixed condition. In a study
of 446 NAFLD patients with biopsies 4.9±2.8 years apart, Kleiner et al. found that 41.9%
of those with NAFL at baseline progressed to borderline or definite NASH and 12.8%
had complete resolution of NAFLD.145 Among those with definite NASH at baseline,
31.5% showed regression to NAFL or borderline NASH and 10.9% had complete
resolution of NAFLD.145 Similar to the findings by Singh et al., 33.9% of participants had
fibrosis progression. NAFLD progression (NAFL to NASH, or borderline to definite
NASH) was directly associated with fibrosis progression, whereas NAFLD regression
was associated with improvement in fibrosis. Thus, Kleiner et al. showed that NASH can
progress and regress over time and, subsequently, is not a good predictor of fibrosis
progression. Rather, NAFLD disease activity, not the presence of NASH at any given
point, predicts fibrosis progression. Likewise, liver fibrosis can progress and regress over
time.143,145
Co-existing metabolic syndrome components contribute to NAFLD progression
and NAFLD-related mortality. Hypertension143 and type 2 diabetes139,140 have been
associated with fibrosis progression. Comorbid diabetes is associated with increased risk
for cirrhosis and HCC.146,147 Both metabolic syndrome and diabetes can contribute to
liver-related mortality in individuals with NAFLD.148 These relationships are particularly
alarming given that 45-65% of individuals with type 2 diabetes also have NAFLD.149-151
Extrahepatic manifestations of liver disease result in the development or worsening
of comorbidities, such as chronic kidney disease,152,153 type 2 diabetes,138,154 and
cardiovascular disease.155,156 Common cardiac complications in NAFLD include coronary
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artery disease (CAD), structural myocardial alterations, and cardiac arrythmias.156 Not
surprisingly, NAFLD also leads to significant impairments in health-related quality of
life.157,158 Furthermore, these metabolic comorbidities may limit eligibility for liver
transplantation.159
NAFLD is associated with increased risks of liver-specific and all-cause
mortality.160-163 NAFLD-related deaths in the United States have been increasing by an
average of 2% annually, with cirrhosis and cardiovascular disease (CVD) being the
leading causes of death among these.164 Hepatocellular carcinoma, the fourth leading
cause of death overall, is the fastest growing cause of NAFLD-related death, with an
average annual increase of 3.8%.164 While some studies have associated NASH with
mortality,165 emerging evidence has shown that liver fibrosis, not NASH, is a predictor of
mortality.166-168 These findings have been confirmed in a meta-analysis of 5 studies
(N=1,495), which showed that the risk for all-cause mortality increased with fibrosis
stage in a dose-response fashion.169 Additionally, liver-related mortality accounted for a
greater proportion of all deaths in accordance to increased fibrosis stage. Indeed, liverrelated complications become the dominant cause of major health events in patients with
cirrhosis, whereas vascular events and non-hepatic malignancies are predominant in those
with bridging fibrosis (stage 3 per METAVIR scoring system).170
Pathogenesis of NAFLD
Early research on NAFLD led to a “two-hit hypothesis,” which proposed that
insulin resistance (IR) and obesity led to the accumulation of fatty acids in the liver (first
hit), predisposing the liver to necroinflammation and oxidative stress (second hit),
resulting in fibrogenesis.171 However, a “multiple-hit hypothesis” was later proposed 172
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and has sustained its credibility.173 The multiple-hit theory describes the pathogenesis of
NAFLD as a complex, dynamic interplay between behavioral, environmental, and genetic
factors. Insulin resistance (IR), inflammation, and oxidative stress are some of the key
mechanisms implicated in the development and progression of NAFLD. Sedentary
behaviors and poor dietary habits contribute to IR, which in turn promotes the
accumulation of fatty acids in hepatocytes, adipose tissue dysfunction, and inflammation.
In the context of NAFL, the accumulation of free fatty acids in the liver, along with
compromised disposal of fatty acids, lead to the formation of lipotoxic metabolites that
result in inflammation and oxidative stress. As described earlier, individuals may
fluctuate between NAFL and NASH over time, resulting in NASH being a poor predictor
of NAFLD-related outcomes. However, NASH drives fibrogenesis, which is the most
important prognostic factor for health outcomes in NAFLD.174
Food Insecurity and NAFLD
A study using NHANES data from the 2005-2006 cohort found that individuals
with marginal and low food security, combined, compared to those with high food
security, had increased odds for self-reported liver problems (odds ratio [OR]: 2.06, 1.13–
3.79; p=0.022).175 However, to date, only Golovaty et al. have directly examined the
relationship between food insecurity and nonalcoholic fatty liver disease (NAFLD).176
The study used NHANES (2005-2014) data and included 2,627 adults with median age of
43 (30–62) years, who lived below 200% of the federal poverty threshold, were
seronegative for hepatitis B and C viruses, and reported no heavy drinking. NAFLD was
assessed using the U.S. Fatty Liver Index177 and advanced liver fibrosis was determined
with the NAFLD Fibrosis Score.178 In total, 29% of participants lived in food-insecure
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households. The estimated prevalence of NAFLD was of 32% and that of advanced liver
fibrosis was 5%. Food insecurity was significantly associated with higher odds of
NAFLD (OR: 1.38, 95% CI: 1.08, 1.77; p<0.01) and advanced fibrosis (OR: 2.20, 95%
CI: 1.27, 3.82; p<0.01), adjusted for sociodemographic (age, sex, household income,
household size, ethnicity, education) and behavioral factors (alcohol and smoking
history). Food insecurity was also significantly associated with higher odds of obesity
and diabetes. Further analysis showed dose-response relationships between the severity
of food insecurity and both NAFLD and advanced liver fibrosis.
The analysis by Golovaty et al. suggests that food insecurity may contribute to
NAFLD prevalence among low-income U.S. adults. The relationship may be in part due
to poor diet quality, which is often a consequence of food insecurity,39,179 and has been
associated with increased risk for NAFLD.180-182 Moreover, in the United States, patients
with chronic liver disease are more likely to be unemployed and disabled, and have
higher health care expenditures than those without chronic liver disease.183 Thus, food
insecurity may promote liver disease, and in turn, chronic liver diseases may increase
vulnerability to financial instability and food insecurity. Nonetheless, the study is limited
by its use of indirect indexes of liver disease. Moreover, whether the effect of food
insecurity on NAFLD risk may differ for PLWH remains unknown.
Cognitive Disorders in People Living with HIV
Advances in antiretroviral drugs have increased longevity for PLWH, leading to a
growing prevalence of older adults living with HIV.184 In the United States, over half
(51%) of all PLWH are now 50 years of age and older185 compared to 35% in 2010.186 As
PLWH live longer, age-related comorbidities have become the primary causes of
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morbidity and mortality among PLWH.187-191 Moreover, HIV infection results in
accelerated immunosenescence, pre-mature aging,192-194 and the development of ageassociated conditions approximately a decade earlier than HIV-uninfected peers.195,196
Among these conditions are neurocognitive disorders (NCDs), which despite advances in
treatments, continue to affect a significant portion of PLWH.197
“Cognitive impairment” is a broad term used to describe losses in mental functions,
whereas “neurocognitive impairment” (NCI) emphasizes underlying structural or
metabolic brain disruptions that can be objectively measured.198,199 The American
Psychiatric Association’s Diagnostic and Statistical Manual (DSM-5) recognizes
delirium, mild NCDs, and major NCDs (i.e. dementia) that are acquired, rather than
developmental, and represent a loss of cognitive function.200 The DSM-5 defines NCDs
as affecting one or more of the following cognitive domains: complex attention,
executive function, learning and memory, language, perceptual-motor function, and
social cognition.200 Numerous etiologies for NCDs are delineated, including NCD due to
HIV infection. The term HIV-associated neurocognitive disorders (HAND) encompasses
the different neuropathological complications of HIV.201 The most widely used
diagnostic criteria identifies three distinct categories of HAND: asymptomatic
neurocognitive impairment (ANI), mild neurocognitive disorder (MND), and HIVassociated dementia.202 Thanks to widespread use of ART, HIV-associated dementia is
now relatively rare with a 2-4% prevalence.197 However, mild cognitive impairments
have been reported in up to 50% of PLWH, depending on prior or current AIDS
diagnosis,197 and persist despite long-term viral suppression.203 That said, some have
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expressed concerns about the clinical validity of ANI,204 and more conservative
diagnostic criteria estimates the prevalence of HAND around 14-28%.205
HIV infection directly contributes to cognitive dysfunctions. HIV-associated
cognitive impairments are most frequently related to executive dysfunction, particularly
affecting working memory.206 The neurodegenerative effects of HIV infection are
thought to occur, at least in part, through its pro-inflammatory properties.207-209 A number
of studies have indicated a role of increased levels of pro-inflammatory cytokines in
cognitive impairment and decline.210,211 HIV infection results in hyper-activation of the
immune system, persistent inflammation, and elevated production of pro-inflammatory
cytokine/chemokines from monocytes and macrophages.212-214 Indeed, several studies
have supported the association between pro-inflammatory cytokines and HIV-related
neurodegeneration.215-220
Nonetheless, other factors contribute to cognitive impairments in PLWH.
Depression is highly and disproportionately prevalent among PLWH221 and contributes to
substantial cognitive impairments in this population.222 Liver disease, a major cause of
morbidity and mortality among PLWH,223 has been associated with NCI in PLWH, even
in the absence of viral hepatitis.224-226 Yet, co-infection with hepatitis C virus (HCV) is
common among PLWH227 and is itself associated with cognitive impairments228,229
irrespective of advanced liver disease, cirrhosis, or substance abuse.230,231 That said, those
who are HIV/HCV co-infected show greater cognitive deficits than HIV and HCV monoinfected individuals.232,233
Furthermore, nutritional risk factors such as food insecurity, malnutrition, and
obesity may contribute to cognitive impairments in PLWH. Food insecurity65 and
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obesity234 are prevalent among PLWH, and food insecurity has been associated with both
malnutrition and obesity in PLWH.79,235 Food insecurity236 and obesity237,238 have been
identified as risk factors for cognitive impairment in PLWH, while underweight has been
associated with progression of mild cognitive impairment to dementia in HIV-uninfected
elderly.239 Others have reported associations between decreased cognitive function and
central (abdominal) obesity, as measured by waist circumference or waist-to-hip ratio.240242

Additionally, obesity is tightly associated with fatty liver and is a risk factor for

progression of liver disease to cirrhosis,243 further contributing to the risk for cognitive
impairment.
Assessment of Cognitive Impairment
Neuropsychological assessments are the primary diagnostic measures for NCDs.
Cognitive assessments are designed to evaluate specific cognitive domains in an
objective, quantitative, and standardized manner. They can be administered noninvasively and are able to detect early signs of cognitive decline in patients unaware of
their own cognitive functioning or those that may not present with physical signs of a
neurodegenerative disease. Neuropsychological batteries are employed to evaluate broad
cognitive function in multiple domains. However, neuropsychological batteries are timeintensive, must be administered by a trained professional, and are not necessary for all
patients suspected of NCI. Consequently, several screening tools have been designed to
assess global mental status in clinical settings, with low burden to patients and healthcare
providers, allowing for monitoring of cognitive decline with repeated assessments over
time.244,245 The most widely used and well-studied cognitive assessment tool for
screening NCDs is the Mini-Mental State Examination (MMSE).246 A comprehensive
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meta-analysis of 108 cohort studies and 10,263 patients by Tsoi et al. found that the
MMSE had a sensitivity and specificity of 81% and 89%, respectively, for the detection
of dementia.244 However, Tsoi et al. also found that data from 21 cohort studies yielded a
62% sensitivity and 87% specificity for mild NCD using the MMSE.244 Indeed, cognitive
assessment screening tools are insufficiently sensitive to mild NCD. As a general
guideline, mild cognitive impairment is considered when performance on cognitive
testing that falls between 1-2 standard deviations (SD) below the mean.198 Importantly,
these screening measures cannot diagnose NCDs − a positive result requires further
testing.
Food Insecurity and Cognitive Impairment
Overall, studies show that food insecurity is associated with cognitive impairments.
Some studies have associated food insecurity in early life with cognitive impairments in
older age.247-249 The adverse effect of food insecurity on cognitive outcomes has been
reported in poor-resource countries.248,250,251 Table 2.2 summarizes the available literature
on food insecurity and cognitive impairment from studies conducted in the United States
In a sample of 350 homeless older adults, cognitive impairment was associated with
greater odds of VLFS (adjusted OR: 2.21, 95% CI 1.12−4.35).252 Gao et al. investigated
the relationship between food insecurity and cognitive function among 1,358 Hispanic
adults of ages 45−75 years from the Boston Puerto Rican Health Study (BPRHS).253 Very
low food insecurity was associated with lower MMSE scores (adjusted means 22.5±0.4
vs 23.4±0.1, p<0.001) and higher odds for cognitive impairment (adjusted OR: 2.28; 95%
CI: 1.26, 4.12). On the MMSE subscales, food insecurity was associated with lower
scores on executive function (p=0.003 for trend), but not memory or attention. The
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investigators also performed a neurocognitive battery and food insecurity was associated
with lower scores for word-list learning, percentage retention, letter fluency, and digit
span backward. In a subsequent study from the BPRHS, Wong et al. used a longitudinal
design to assess the relationship between food insecurity and changes in cognitive
function over a 2-year period.254 The study included 597 Hispanic adults ages 45−75
years, without cognitive impairment (MMSE ≥ 24) at baseline. Food insecurity, measured
only at baseline, was associated with a 2-year decline in global cognition, even after
adjustment for sociodemographic characteristics, baseline MMSE score, BMI, and
depression symptoms. Again, VLFS was associated with a decline in executive function,
but was not associated with changes in the memory domain. Furthermore, the
investigators observed that the association between food insecurity and global cognitive
decline was more pronounced in participants with baseline MMSE ≥ 27 or those who
lived in poverty.
Frith & Loprinzi used NHANES 1999-2002 data from 1,851 older adults (60−85
years old) to assess the effect of food insecurity on cognitive function, as measured by the
Digital Symbol Substitution Test.255 The results of the study showed lower cognitive
function in participants with marginal, low, and VLFS compared to participants who
were fully food-secure. Although the study was limited by its use of a single cognitive
measure, a later study by Portela-Parra & Leung showed similar results using a more
robust cognitive assessment. Using NHANES 2011−2014 data from 1,823 older adults
with incomes below 300% of the federal poverty level, Portela-Parra & Leung found that
food insecurity was inversely associated with cognitive function.256 Specifically, food
insecurity was associated with worse performance on processes related to executive
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function: processing speed, sustained attention, verbal fluency, working memory, and
immediate learning ability.
Food Insecurity and Cognitive Impairment in PLWH
Despite the high prevalence of food insecurity and cognitive impairments among
PLWH, only two cross-sectional studies have examined how food insecurity may
contribute to cognitive impairment in PLWH. In a study by Hessol et al., food insecurity
was not associated with cognitive impairment as determined with the Montreal Cognitive
Assessment (MoCA) in 229 PLWH ages 50 years and older.257 On the other hand,
Hobkirk et al. used a neurocognitive battery to assess the effects of food insecurity on the
neurocognitive performance of 61 PLWH and 36 HIV-uninfected middle-aged adults.236
The investigators found significant interaction effects of HIV and food insecurity on
speed of information processing, learning, memory, and motor function, as well as a
global deficit score−an average of the deficit scores for all domains. Among PLWH, food
insecurity was associated with significantly higher domain deficit scores in the domains
of speed of information processing, learning, motor function, and the global deficit score,
but not memory. On the other hand, there were no significant differences in domain
deficit scores in relation to food insecurity among participants uninfected with HIV;
however, this may be a result of the small sample size. Moreover, food insecurity was not
associated with viral load suppression, nadir or recent CD4 cell count, length of HIV
infection, AIDS diagnosis, HCV infection, or ART adherence, suggesting that the effects
of food insecurity were independent of these factors.
These studies demonstrate a need for further research to understand the relationship
between food insecurity and cognitive impairment in PLWH. The lack of findings by
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Hessol et al.257 may be due to insufficient sensitivity of screening assessments for mild258
or HIV-associated cognitive impairments.259 While the findings by Hobkirk et al. provide
robust evidence for the effect of food insecurity on cognitive dysfunction, the small
sample of HIV-uninfected participants does not allow to infer that this effect differs in
PLWH from HIV-uninfected persons.236 Additionally, the cross-sectional design does
now allow for temporality to be established.
Although the findings are generally consistent, the existing evidence is limited by
heterogeneity in samples, food insecurity measurements, and time-frames.260 Few
longitudinal studies are available, and none have applied multiple food insecurity
measures to determine the effects of frequency and duration of food insecurity on
cognitive impairment.
Immune Activation in HIV Infection
Infection with HIV results in chronic activation of the immune system. While
activation of immune responses is beneficial in removing pathogens and resolving
infectious processes, chronic activation can be deleterious.261 Left untreated, rapid and
persistent HIV replication leads to progressive immunodeficiency, accelerated immune
senescence (age-associated decline in immune function), and the development of
AIDS.192,262 Modern ART has been effective at controlling viral replication and
improving longevity for PLWH.263,264 Nonetheless, persistent immune activation and
inflammation, even with effective ART and virologic suppression,265,266 contribute to
high rates of chronic comorbidities among PLWH, including cardiovascular disease, type
2 diabetes, liver disease, non-AIDS-defining cancers, and HIV-associated neurocognitive
disorders.267-276
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One of the major mechanisms thought to contribute to systemic immune activation
in PLWH is the infiltration of pathogens and other toxic microbial products through the
intestinal epithelial barrier, known as microbial translocation.277,278 Early in the infection,
HIV targets CD4+ T-cells in the gut-associated lymphoid tissue, where the majority of
immune cells reside in the human body.279 Subsequently, HIV weakens gut integrity,
leading to microbial translocation and an inflammatory cascade.
Biomarkers of Immune Activation
Monocytes and macrophages play an essential role in innate immunity against
pathogens and contribute to adaptive, long-term immunity. These cells promote
phagocytosis, release reactive oxygen species (ROS), produce inflammatory cytokines,
and modulate T-cell immune response.280 Inflammatory conditions, such as
atherosclerosis, stimulate circulating (inactive) monocytes, leading to macrophage
polarization into M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotypes,
depending on the stimuli.281 Therefore, activation of monocytes and macrophages is
critical in immune responses to acute stimuli, but chronic activation leads to adverse
downstream effects. Several blood biomarkers of monocyte/macrophage activation have
shown great prognostic value for health outcomes in PLWH. In particular, sCD14 and
sCD163 have been well-characterized in the context of HIV.282
Soluble CD14 (sCD14) is shed by CD14-expressing monocytes after stimulation by
lipopolysaccharide (LPS), also known as endotoxin, a marker of microbial translocation
derived from the cell wall of gram-negative bacteria.283 Consequently, sCD14 highly
correlates with LPS levels284,285 and serves as an indirect, yet non-specific marker of
microbial translocation.277,283 Elevated levels of sCD14 persist during effective
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suppressive ART and correlate with HIV disease progression.283,286 Additionally,
elevated sCD14 has been associated with several chronic conditions, including
cardiovascular disease,287-289 chronic kidney disease,290 alcoholic and nonalcoholic liver
diseases,291-295 dementia296 and HIV-associated neurocognitive disorders,276 as well as
mortality in PLWH.297,298
CD163, also known as hemoglobin scavenger receptor, is expressed almost
exclusively on monocytes and macrophages.299,300 Shedding of sCD163 in plasma has
been implicated in chronic inflammatory conditions.299,300 Effective ART decreases
sCD163 levels in PLWH, but these only return to HIV-seronegative levels among those
who initiate ART early in the infection.286,301 Consequently, sCD163 serves as a marker
of HIV disease progression, correlated directly with HIV viral loads and inversely with
CD4 cell count,301 and shown to predict mortality in PLWH.302 Moreover, sCD163 serves
as a marker of Kupffer cell activation that is highly correlated with liver disease severity
and mortality.303 Elevated sCD163 was associated with advanced liver fibrosis and
cytokeratin-18 (a marker of hepatocyte apoptosis) among histologically-determined
NAFLD patients.304 In one study, levels of sCD163 in plasma, but not in cerebrospinal
fluid (CSF), correlated with the severity of HAND.305 In another study, however, levels
of sCD163 in cerebrospinal fluid were inversely correlated with cognitive function.306
Another useful biomarker is CD27, a transmembrane glycoprotein of the tumor
necrosis factor receptor (TNF-R) family that is expressed on peripheral T and B
lymphocytes.307 Soluble CD27 is secreted by antigen-stimulated T-cells, thus considered
a direct marker of early-stage T-cell activation. Levels of sCD27 are responsive to ART
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but remain elevated in HIV infection, correlate with HIV disease progression, and have
been particularly associated with AIDS-associated lymphoma.265,307-310

Food Insecurity and Immune Dysfunction in HIV
Several lines of evidence have linked food insecurity with inflammation and
immune dysregulation (Table 2.3). Studies conducted with NHANES data have
consistently demonstrated that food insecurity is associated with elevated levels of Creactive protein (CRP), a common marker of systemic inflammation.311-313 Moreover,
Gowda et al. showed that the relationship between food insecurity and CRP was partially
mediated by elevated white blood cell counts, suggesting a potential role of immune
activation.311 Also using NHANES data, Bergmans et al. reported on the association
between food insecurity and the inflammatory potential of the diet, showing a doseresponse relationship between the severity of food insecurity and Dietary Inflammatory
Index (DII) scores.314 Based on a meta-analysis of 1,943 studies, the DII was designed to
assess the impact of diets on the following six inflammation biomarkers: interleukin(IL)1β, IL-4, IL-6, IL-10, tumor necrosis factor-alpha (TNF-α), and CRP.315
Recently, the Women’s Interagency HIV Study (WIHS) has associated food
insecurity with inflammation and immune dysregulation in women living with HIV on
stable ART.316,317 Leddy et al. showed that food insecurity was significantly associated
with higher concentrations of pro-inflammatory cytokines IL-6 and TNFR-1.316 Peters et
al. found that food insecurity was associated with increased CD4+ and CD8+ activation
(%CD38+HLADR+), increased senescence of CD8+ T cells (%CD57+CD28−),
increased exhaustion of CD4+ T cells (%PD-1+), and decreased co-stimulation of CD4+
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and CD8+ T cells (%CD57− CD28+), after adjusting for confounders.317 These
association were particularly pronounced among those with higher viral loads and lower
CD4 cell counts.
The associations between food insecurity and markers of inflammation and
immune dysregulation point to a biological pathway between food insecurity and chronic
disease. For example, among 121 Latinos with type 2 diabetes, cortisol and CRP partially
mediated the relationship between food insecurity and insulin resistance, the precursor to
type 2 diabetes.40 Notably, insulin resistance is a key pathological mechanism in NAFLD
development and progression,173,318 a relationship likely mediated by inflammation.319
Insulin resistance is also associated with cognitive dysfunction320 and cognitive
decline.321 In another study, food insecurity was associated with the primary allostatic
system (neuroendocrine and inflammatory), which incorporated serum cortisol and CRP
as biomarkers of stress and inflammation, respectively.322 Thus, the overall findings of
these studies suggest that food insecurity has the potential to promote immune activation
(and inflammation) among PLWH, and thereby contribute to chronic diseases, including
NAFLD and cognitive dysfunction, in this population.

Summary of Literature Review
Food insecurity is an important social determinant of health that disproportionately
impacts PLWH. Already at increased risk for nutrition-related complications, chronic
metabolic diseases, and mental health disorders, food insecurity may have a significant
impact on the disease burden of PLWH. While food insecurity has been associated with
NAFLD risk factors, such as obesity, diabetes, and the metabolic syndrome, only one
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study has examined its association with NAFLD using indirect indexes of liver disease.176
Whether food insecurity contributes to NAFLD in PLWH, a population at increased risk
for liver disease,112,116 poor diet,323 and their related consequences, has not been
previously investigated. There is evidence that food insecurity is associated with
cognitive impairments; however, only one cross-sectional study has previously examined
how food insecurity impacts cognitive function in PLWH.236 Moreover, few longitudinal
studies are available in this area of research, and no studies have examined the role of
transient or persistent food insecurity on cognition.
Several mechanisms are thought to mediate the relationship between food
insecurity and chronic diseases. Poor diet quality, unhealthy eating behaviors, and
negative coping mechanisms have been suggested to play a role in the effects of food
insecurity on health outcomes. Some studies have also indicated that inflammation may
be a potential biological pathway in this relationship. However, the relationship between
food insecurity and immune activation, considered a key factor in adverse health
outcomes among PLWH, has not been examined.
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Table 2.1. Non-invasive Assessments for NAFLD
Liver Steatosis

Biological
Fatty Liver Index (FLI)
BMI, waist circumference, triglycerides, and GGT
U.S. FLI
Age, race/ethnicity, waist circumference, GGT, fasting
insulin, and fasting glucose
Hepatic Steatosis Index (HSI)
BMI, diabetes, and ALT/AST ratio

Liver Fibrosis

NAFL Screening Score
Age, fasting blood glucose, BMI, triglyceride, ALT/AST
ratio, and uric acid
Fibrosis-4 Index (FIB-4)
Age, AST, ALT, platelets
AST-to-Platelet Ratio Index (APRI)
AST, platelets
NAFLD Fibrosis Score (NFS)
Age, BMI, hyperglycemia, AST/ALT ratio, platelets, and
albumin

Imaging
Ultrasound (US)
Computed tomography (CT)
Controlled attenuation parameter (CAP)
Magnetic resonance imaging-derived proton
density fat fraction (MRI-PDFF)

Transient elastography (TE)
Shear wave elastography (SWE)
Acoustic radiation force impulse (ARFI)
Magnetic resonance elastography (MRE)

Enhanced Liver Fibrosis (ELF)
2.278+0.851 ln(HA)+0.751 ln(P3NP)+0.394 ln( TIMP-1)
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; HA, hyaluronic acid; P3NP,
propeptide of procollagen type III; TIMP-1, tissue inhibitor of matrix metalloproteinases-1
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Table 2.2. Summary of Studies on Food Insecurity and Cognitive Impairment
Author,
Date
Design

Population

Food
Insecurity

1,358 Hispanic
HFSS
adults from the
BPRHS, ages 45-75
years

Cognitive Impairment

Main Findings

Primary: MMSE < 24
Secondary: 16-word list learning test,
digit span forward and back, Stroop
test, verbal fluency, clock drawing,
figure copying

87.9% were food-secure (high and marginal food security),
6.0% had LFS, 6.1% had VLFS. VLFS was associated with
lower MMSE scores (adjusted means 22.5±0.4 vs 23.4±0.1,
p<0.001) and higher odds of cognitive impairment (adjusted
OR: 2.28; 95% CI: 1.26, 4.12) compared to high-marginal
food security. On the MMSE subscales, FI was associated
with lower scores on executive function (p=0.003 for trend),
but not memory or attention. FI was also associated with
lower scores for word-list learning, percentage retention,
letter fluency, and digit span backward.

Wong, 2016 597 Hispanic adults HFSS
from the BPRHS,
ages 40-75 years,
Longitudinal
MMSE ≥ 24 at
baseline

Global Deficit Score (GDS): a
composite score of the MMSE, 16word list learning test, digit span
forward and back, Stroop test, verbal
fluency, clock drawing, figure copying

At baseline, 87.9% were food-secure (high and marginal
food security), 5.5% had LFS, 4% had VLFS.
VLFS was associated with a significant decline in the global
cognitive score (Mdiff: -0.26, 95% CI: -0.41, -0.10)
compared to food security. VLFS was associated with a
decline in executive function (Mdiff: -0.47, 95% CI: -0.77, 0.18), but not memory (Mdiff: -0.08, 95% CI: -0.46, 0.30).

Hessol, 2017 230 PLWH, ages
≥50
Crosssectional

HFSS

MoCA < 26

68% were food-secure (high and marginal food security),
15% had LFS, and 17% had VLFS. Cognitive impairment
was not associated with LFS (OR: 1.15, 95% CI: 0.65–2.03)
or VLFS (OR: 1.27, 95% CI: 0.75–2.16).

Hobkirk,
2017

HFIAS

Neuropsychological battery:
information processing, learning,
memory, executive functioning, verbal
fluency, attention, motor skills
Global Deficit Score (GDS): average of
the deficit scores on all cognitive
domains

49% of PLWH and 44% of HIV-uninfected participants
endorsed at least one FI criteria. Across all participants, FI
was associated with deficit scores speed of information
processing, but not any other domain or GDS. There were
significant FI-HIV interaction effects on information
processing, learning, memory, motor function, and the GDS.
Among PLWH, but not HIV-uninfected, FI was associated
with deficit scores on information processing, learning,
motor function, and the GDS.

Gao, 2009
Crosssectional

Crosssectional

61 PLWH (mean
age 46.3±10.7) and
36 HIV-uninfected
adults (mean age
44.4±12.0)
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Author,
Date
Design
Frith, 2018
Crosssectional
PortelaParra, 2019
Crosssectional

Population

Food
Insecurity

Cognitive Impairment

Main Findings

1,851 adults from
NHANES (19992002), ages 60-85
years

HFSS

Digit Symbol Substitution Test (DSST) 88.5%, 5%, 4.4%, and 2.1% had full, marginal, low, and
VLFS, respectively. Compared to fully food security,
marginally (β= -13.4; 95% CI: -17.6, -9.2), LFS (β=-10.9;
95% CI: -17.6, -4.1) and VLFS (β= -22.2; 95% CI: -28.6, 15.8) had significantly lower DSST scores.

1,823 adults from
NHANES (20112014), ages ≥60
years, < 300%
poverty level

HFSS

CERAD word learning, CERAD
delayed word recall, the Animal
Fluency Test (AFT), DSST
Overall cognitive function score:
average of individual tests

Modified MMSE (3MS) < 1.5 SD from 44.6% had high-marginal food security, 31.1% had LFS,
the mean (< 7th percentile)
24.3% had VLFS. 25.8% had cognitive impairment.
Cognitive impairment was associated with 2.21 (1.12, 4.35)
times the odds for VLFS, adjusted for confounders.
Abbreviations: BPRHS, Boston Puerto Rican Health Study; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; DSST, Digit Symbol
Substitution Test; FI, food insecurity; GDS, global deficit score; HFIAS, Household Food Insecurity Access Scale; HFSS, U.S. Household Food
Security Survey; LFS, low food security; Mdiff, mean difference; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment;
NHANES, National Health and Nutrition Examination Survey; VLFS, very low food security
Tong, 2019
Crosssectional

350 homeless adults, HFSS
ages 58 (54-61)
years

23.7% were food-insecure. FI was associated with lower
scores on the CERAD word learning subtest (β= −0.14, 95%
CI: −0.26, −0.01), AFT (β= −0.13, 95% CI: −0.25, −0.002),
DSST (β=−0.24, 95% CI: −0.33, −0.15), and overall
cognitive function (β= −0.15, 95% CI: −0.26, −0.05).
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Table 2.3. Summary of Studies on Food Insecurity and Immune Dysfunction
Author,
Date
Design
Gowda,
2012

Population

Food
Insecurity

Outcome

Main Findings

12,191 adults from
NHANES 1999-2006,
ages ≥18 years

HFSS

CRP, WBC

7.5% were marginally food-secure and 14.0% had low or VLFS.
FI (low or VLFS) was associated with 1.21 (95% CI: 1.04, 1.40) times
the odds of being in the highest quartile of CRP and 1.36 (95% CI: 1.11,
1.67) times the odds of having high WBC count (>10,000/µL) compared
to food security, adjusted for confounders. WBC count was a partial
mediator between FI and CRP (Sobel test p<0.001).

10,455 adults from
NHANES 2003-2008,
ages ≥20 years

HFSS

CRP > 3 mg/L

6.7% had marginal, 5.8% had low, and 3.6% had VLFS.
VLFS was associated with higher mean CRP (4.8 vs. 3.9, p=0.04), a
higher prevalence of elevated CRP (42.4 vs. 31.5%, p<0.001), and 1.25
(95% CI: 1.03, 1.51) times the odds for elevated CRP compared to full
food security, adjusted for confounders. However, the increased risk for
elevated CRP was lost when additionally adjusted for HbA1c, systolic
blood pressure, total cholesterol, high-density lipoprotein cholesterol,
body mass index, and urinary albumin-creatinine ratio (adjusted OR:
0.98, 95% CI: 0.82, 1.18).

Bergmans,
2018
Crosssectional

10.630 adults from
NHANES 2007-2014,
ages ≥20 years, and
income-to-poverty ratio
≤3.0

HFSS

DII

14.4% had marginal, 17.3% had low, and 10.7% had VLFS.
FI was associated with a dose-response effect on DII scores: marginal
(β=0.14, 95% CI: -0.04, 0.32), low (β=0.17, 95% CI: 0.02, 0.32), and
VLFS (β=0.31, 95% CI: 0.12, 0.49) having increasingly higher mean DII
scores compared to full food security, adjusted for covariates.

BermudezMillan,
2019
Crosssectional

121 Latino/Hispanic
adults with type 2
diabetes, ages 60.7±11.6
years

6-item
hs-CRP
HFSS, short
form

Crosssectional
Ford, 2013
Crosssectional

68% were classified as food insecure.
FI was associated with higher hs-CRP (10.5±12.9 vs. 9.7 ± 26.1,
p=0.008). Hs-CRP (and cortisol) partially mediated the relationship
between FI and HOMA-IR.
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Author,
Date
Design

Population

Leddy, 2019 421 HIV+ women on
ART, ages 47 (40–52)
years
Cross79% were virally
sectional
suppressed (<20
copies/mL) and 70% had
CD4 cell count ≥500
cells/mm3

Food
Insecurity
HFSS

Outcome

Main Findings

IL-6
TNFR1

31% were food-insecure (marginal, low, or VLFS).
FI was associated with 1.23 times higher IL-6 (95% CI: 1.06–1.44) and
1.13 times higher TNFR1 (95% CI: 1.05–1.21), adjusted for confounders.
Dietary intakes were not associated with the inflammatory markers.

Peters, 2020 241 HIV+ women on
HFSS
CD4+ and CD8+: 43% were food-insecure (marginal, low, or VLFS).
ART, ages 46 (40–50)
%CD38+HLADR+ FI was associated with increased CD4+ and CD8+ activation
years
(%CD38+HLADR+), increased senescence of CD8+ T cells
Cross%CD57+CD28−
74.6% were virally
(%CD57+CD28−), increased exhaustion of CD4+ T cells (%PD-1+), and
sectional
%PD-1+
suppressed (<40
decreased co-stimulation of CD4+ and CD8+ T cells (%CD57− CD28+),
%CD57− CD28+ after adjusting for confounders.
copies/mL) and 68.3%
had CD4 cell count ≥500
There were no significant differences in sCD14, sCD163, or I-FABP
cells/mm3
Abbreviations: CRP, C-reactive protein; DII, Dietary Inflammatory Index; FI, food insecurity; HOMA-IR, homeostasis model assessment of insulin
resistance; hs-CRP, high-sensitivity C-reactive protein; I-FABP, intestinal fatty acid binding protein; IL, interleukin; TNFR, tumor necrosis factor
receptor; WBC, white blood count
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CHAPTER III: ASSOCIATION OF FOOD INSECURITY WITH
NONALCOHOLIC FATTY LIVER DISEASE 1
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver
disease in the United States. Food-insecure individuals often depend on low-cost, energydense but nutritionally-poor foods, resulting in obesity and chronic diseases related to
NAFLD.
Objective: To determine whether food insecurity is associated with NAFLD in a cohort
of HIV and HCV infected and uninfected adults.
Methods: Cross-sectional analysis of low-income, middle-aged adults from the Miami
Adult Studies on HIV (MASH) cohort without history of excessive alcohol consumption.
Food security was assessed with the USDA’s Household Food Security Survey. Magnetic
resonance imaging was used to assess liver steatosis and fibrosis. Metabolic parameters
were assessed from fasting blood, anthropometrics, and vitals.
Results: Of the total 603 participants, 32.0% reported food insecurity. The prevalence of
NAFLD, fibrosis, and advanced fibrosis were 16.1%, 15.1%, and 4.6%, respectively. For
every 5 kg/m2 increase in BMI, the odds of NAFLD increased by a factor of 3.83 (95%
CI: 2.37, 6.19) in food-insecure participants compared to 1.32 (95% CI: 1.04, 1.67) in
food-secure participants. Food insecurity was associated with increased odds for any liver
fibrosis (OR:1.65, 95% CI: 1.01, 2.72) and advanced liver fibrosis (OR: 2.82, 95% CI:

1

Reprinted from: Tamargo JA, Sherman KE, Campa A, et al. Food insecurity is associated with magnetic
resonance–determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with
and without HIV. Am J Clin Nutr. 2021;113(3):593-601. doi:10.1093/ajcn/nqaa362
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1.22, 6.54), adjusted for confounders. HIV and HCV infections were associated with
increased risk for fibrosis, but the relationship between food insecurity and liver fibrosis
did not differ from uninfected participants.
Conclusions: Among low-income, middle-aged adults, food insecurity exacerbated the
risk for NAFLD associated with higher BMI and independently increased the risk for
advanced liver fibrosis. People who experience food insecurity, particularly those
vulnerable to chronic diseases and viral infections, may be at increased risk for liverrelated morbidity and mortality. Improving access to adequate nutrition and preventing
obesity among low-income groups may lessen the growing burden of NAFLD and other
chronic diseases.

Introduction
Food insecurity is a socioeconomic condition in which households experience
inadequate access to sufficient and nutritious foods.1 Individuals who experience food
insecurity often depend on low-cost, energy-dense but nutritionally-poor foods, usually
consisting of refined carbohydrates, added sugars, fats, and sodium.2 Food insecurity is
also associated with overconsumption when food is available,3,4 but not necessarily with
lower energy intakes.5 These factors result in food insecurity contributing to obesity and
associated chronic diseases.6,7 Food insecurity is reported by 14.3 million (11.1%)
households in the United States, disproportionately affecting minorities and other
marginalized groups.1,8
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver
disease in the United States and other Western countries, with a rise in prevalence that
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parallels that of obesity9 and metabolic syndrome (MetS).10 Between a quarter and a third
of all U.S. adults11-13 are estimated to have NAFLD, which encompasses nonalcoholic
fatty liver (liver steatosis), nonalcoholic steatohepatitis (NASH), and cirrhosis in the
absence of significant alcohol consumption or hereditary disorders.14 Chronic hepatocyte
injury caused by hepatitis infection, heavy drinking, and NAFLD/NASH leads to liver
fibrosis, or the scarring of liver tissue. Even after sustained virological response of
chronic hepatitis C, older age and high body mass index are associated with persisting
fibrosis.15 Advanced liver fibrosis can result in liver failure, portal hypertension, and
cirrhosis, which may require liver transplantation. While the relationship between food
insecurity and liver diseases has remained largely unexplored, Golovaty et al. found an
association between food insecurity and increased risk of NAFLD and advanced liver
fibrosis among low-income U.S. adults.16
People living with HIV (PLWH) are among those disproportionately affected by
socioeconomic hardships and stigma,17 including food insecurity.18-21 Additionally,
PLWH are at increased risk for chronic diseases,22,23 including liver diseases.24 Moreover,
due to several compounding factors, liver disease progression is accelerated in PLWH.25
As viral hepatitis infections are increasingly treated, the burden of fatty liver disease
among PLWH has garnered recognition.25 In PLWH, NAFLD is estimated in 30-65%26,27
and liver fibrosis in 8-17%.28,29 Both in the general population30,31 and PLWH,32,33 food
insecurity has been linked to substance abuse, which in turn may result in increased risk
for liver disease.34 We have shown that cocaine use is a risk factor for liver fibrosis35-37
and mortality in PLWH.36
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While liver biopsy is considered the “gold standard” for determining NAFLD and
liver fibrosis, it is costly and invasive with potential health complications in addition to
high inter- and intra-observer variability.38 Magnetic resonance (MR)-based assessments,
such as MR imaging-derived proton density fat fraction (MRI-PDFF) and MR
elastography (MRE), are currently regarded as the most accurate noninvasive techniques
for assessment of liver steatosis and fibrosis, respectively.39-42 The objective of this study
was to determine whether food insecurity is associated with NAFLD using accurate, noninvasive MR technology in a cohort of HIV and/or hepatitis C virus (HCV) infected and
uninfected adults.
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Methods
Study subjects
The study consisted of a cross-sectional analysis of baseline data from the Miami
Adult Studies on HIV (MASH) cohort, which follows people living with and without
HIV for patterns of substance use and health disparities, with a focus on liver disease and
related comorbidities. From October of 2016 through February of 2020, 1,031 MASH
cohort participants had completed a baseline assessment. Participants in the MASH
cohort are 40 years of age or older and seronegative for hepatitis B virus. This study was
approved by the Florida International University Institutional Review Board and all
participants provided written consent for participation in the study, release of medical
information, and MR assessments. Exclusion criteria consisted of contraindications for
MR (e.g., claustrophobia, ferromagnetic implant, poor fit due to body size [waist
circumference greater than ~55 inches/140 cm]), self-reported current or prior alcohol
consumption of more than 14 drinks per week for women and 21 for men,14 underweight,
and documented inherited liver disease (e.g., Wilson’s disease) from medical records.
Food insecurity
Food insecurity was determined with the USDA’s 18-item Household Food
Security Survey, which assesses a respondent’s perceived food sufficiency and adequacy,
food-related anxiety, and instances of hunger that occurred in the household during the
past 12 months.43 The total sum of affirmative responses was used to categorize food
security status as food-secure (scores 0−2) or food-insecure (scores ≥3). We further
explored food insecurity by levels of severity as follows: full food security (score of 0),
marginal food security (scores 1−2), low food security (LFS; scores 3−7 for households
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with children and 3−5 without children), and very low food security (VLFS; scores ≥8
with children and ≥6 without children).
Outcomes
The primary endpoints of this study were the presence of nonalcoholic fatty liver
(steatosis) and fibrosis. Liver fat content was assessed via magnetic resonance imagingderived measurement of proton density fat fraction (MRI-PDFF). Liver fibrosis was
assessed via liver stiffness (LS) measurement by magnetic resonance elastography
(MRE). These were conducted on a 3T Siemens MAGNETOM Prisma scanner. NAFLD
was considered present if MRI-PDFF >5%.14 Liver fibrosis was defined as LS ≥2.9 kPa,
which is consistent with histologically-proven liver fibrosis stage 1 or higher, and
advanced fibrosis was defined as LS ≥3.8 kPa, consistent with histologically-proven liver
fibrosis stage 3 or higher.44
Covariates
Demographic data were self-reported. Substance use was determined by self-report
and urine drug screen, including tobacco, marijuana, cocaine, methamphetamines, and
opiates. Alcohol consumption was determined as drinks per week from self-report.
Anthropometrics and blood pressure were measured by trained research staff. Fasting
blood samples were used to evaluate serum concentrations of glucose, triglycerides, and
liver enzymes. Insulin resistance was measured with the triglyceride and glucose (TyG)
index,45,46 calculated as:
𝐿𝐿𝐿𝐿(𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 [𝑚𝑚𝑚𝑚⁄𝑑𝑑𝑑𝑑] ∗ 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔[𝑚𝑚𝑚𝑚/𝑑𝑑𝑑𝑑])/2

HIV and HCV viral loads and CD4 cell counts were abstracted from medical
records. HIV viral suppression was defined as plasma HIV RNA <200 copies/mL. Body
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mass index (BMI) was calculated and expressed in 5 kg/m2 increments. Obesity was
defined as having a BMI ≥30 kg/m2. Criteria for MetS consisted of the presence of any 3
out of the following: abdominal obesity (waist circumference ≥35 inches for women and
≥40 inches for men), hypertriglyceridemia (TG ≥150 mg/dL), reduced high-density
lipoprotein cholesterol (HDL-C) (≤50 for women and ≤40 mg/dL in men), hypertension
(≥130 mm Hg systolic or ≥85 mm Hg diastolic blood pressure), or hyperglycemia
(fasting plasma glucose ≥100 mg/dL).47
Statistical analysis
Descriptive statistics consisted of Chi-square tests for categorical variables and Ttest (or nonparametric Wilcoxon rank-sum test) for continuous variables; reported as No.
(%) and mean ± standard deviation (SD) or median (interquartile range, IQR). Univariate
and multivariable binary logistic regressions were performed for NAFLD, any liver
fibrosis, and advanced fibrosis; estimates reported as odds ratio (OR) or adjusted odds
ratio (AOR) and 95% confidence intervals (CI). Candidates for multivariable regression
models included HIV infection, HCV infection, substance use, and metabolic risk factors.
Variables with P<0.25 in univariate analyses were selected for multivariable analyses.
MetS and TyG index, if significant in univariate analyses, were included in separate
multivariable models in order to avoid multicollinearity since these are composites of
other confounders. In multivariable analyses, variables were removed from the model
until only those factors with P<0.05 remained. Potential interactions between food
insecurity and other confounders were explored by including interaction terms in the
multivariable models. Potentially important sociodemographic confounders and alcohol
consumption were retained in the models to obtain estimates adjusted for these
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confounders. All data analysis was generated using SAS software, Version 9.4. Results
were considered statistically significant at P<0.05 (two-sided).

Results

Figure 3.1. Flow Chart for MASH Cohort Participants Included in This Analysis
Abbreviations: MR – magnetic resonance

Study population
The characteristics of the study population are shown in Table 3.1, consisting of
603 adults. Out of the total 1,031 MASH cohort participants at the time this analysis was
conducted, 428 were excluded for MR scan ineligibility (n=354), excessive alcohol
consumption (n=52), underweight (n=17), or missing important data (n=5) (Figure 3.1).
Excluded participants were less likely to be male and infected with HIV or HCV
(P<0.05), but no other characteristics significantly differed, including food insecurity.
Participants were 55.2±6.2 years old and predominantly male (56.0%) and Black nonHispanic (60.7%). Most were unmarried (89.4%) and without children (91.7%), with
1.8±1.3 members per household. In total, 51.4% of participants were disabled and 36.0%
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were otherwise unemployed. Accordingly, 76.6% of participants lived in households that
fell under the Federal Poverty Level, with 92.5% falling under 185%, and all below
200% of poverty.
A total of 263 (43.6%) participants were living with HIV, 144 (23.9%) were
seropositive for HCV, 64 (10.6%) were coinfected with both HIV and HCV, and 260
(43.1%) were HIV/HCV-uninfected. Of those participants living with HIV, 98.5%
reported antiretroviral therapy (ART) and 84.7% were virally suppressed.
Food insecurity, metabolic parameters, and liver outcomes
A third of participants (32.0%) reported FI, with 87 (14.4)% and 106 (17.6)%
having low and very low food security, respectively, and an additional 107 (17.7%) who
reported marginal food security. Food-insecure participants had lower incomes than those
who were food-secure. Higher proportions of food-insecure participants tended to be
smokers (P=0.09) and cocaine users (P=0.07) than those who were food-secure.
Participants with VLFS were more likely to use more than one illicit substance than foodsecure participants (OR=1.63, 95% CI: 1.11, 2.39; P=0.013). No other characteristic
significantly differed between the two groups (Table 3.1). Most of the participants were
overweight (33.6%) or obese (41.5%), and 21.1% met the criteria for MetS. No
significant difference was observed between food-secure and food-insecure individuals in
any of the metabolic parameters evaluated.
There were 96 (16.1%) participants with NAFLD, 91 (15.1%) with liver fibrosis,
and 28 (4.6%) with advanced fibrosis. As shown in Figure 3.2, food-insecure individuals
had higher proportions of advanced fibrosis (7.8 vs. 3.2%; P=0.01), as well as a tendency
for any liver fibrosis (19.2 vs. 13.2%; P=0.06) compared to food-secure individuals, but
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the frequency of NAFLD did not significantly differ (16.0 vs. 16.1%; P=0.97). However,
food insecurity was associated with a slightly higher but significant mean liver fat content
among obese participants (4.8±2.0 vs. 3.8±1.9%; P=0.03), but not among non-obese
participants (2.5±1.5 vs. 2.8±1.8%; P=0.18); P=0.001 for FI-obesity interaction. No
significant differences were observed in serum values for AST, ALT, and AST/ALT ratio
between food-secure and insecure participants or by levels of food insecurity.
Nonalcoholic fatty liver
Univariate analyses for NAFLD risk are reported in Table 3.2. Food insecurity was
not independently associated with NAFLD. The use of tobacco, cocaine, and cannabis
were significantly associated with decreased odds for NAFLD. People living with HIV or
HCV showed tendencies for lower odds of steatosis compared to uninfected individuals.
Of the metabolic risk factors, BMI, and obesity, MetS, hyperglycemia,
hypertriglyceridemia, abdominal obesity, and TyG index, were associated with NAFLD.
Hypertension and reduced HDL-C were not significantly associated with NAFLD.
Multivariable analyses, shown in Table 3.3, revealed a significant interaction effect
between food insecurity and BMI on the risk for NAFLD (P<0.0001). For every 5-unit
increase in BMI, the odds of NAFLD were 3.83 (95% CI: 2.37, 6.19; P<0.0001) times
higher in food-insecure participants compared to 1.32 (95% CI: 1.04, 1.67; P=0.02) times
higher in food-secure participants. This is visually represented in Figure 3.3, which also
compares the probability for NAFLD between food-secure and food-insecure individuals;
food insecurity was associated with reduced odds for NAFLD at lower BMIs and with
increased odds for NAFLD at higher BMIs. To better illustrate the relationship between
food insecurity and NAFLD given the interaction with BMI, Table 3.3 also shows results
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stratified by the presence of obesity (P=0.003 for interaction). Food insecurity, compared
to food security, was associated with significantly lower odds of NAFLD in non-obese
participants (AOR: 0.30, 95% CI: 0.11, 0.83; P=0.02) and a trend was observed for
higher odds of liver steatosis in obese participants (AOR: 1.85, 95% CI: 0.98, 3.53;
P=0.06).
We further explored the FI-BMI interaction effect on NAFLD risk by levels of food
insecurity and 5-unit increases in BMI; see Table 3.4. Compared to full food security,
VLFS was associated with increased risk for NAFLD at BMIs of 35 and 40 kg/m2, which
correspond to the cutoffs for class II and class III obesity, respectively.
In addition to these findings, hyperglycemia (AOR: 2.48, 95% CI: 1.46, 4.20;
P=0.0008), hypertriglyceridemia (AOR: 2.18, 95% CI: 1.29, 3.67; P=0.004), MetS
(AOR: 3.20, 95% CI: 1.92, 5.32; P<0.0001), and TyG index (AOR: 2.57, 95% CI: 1.78,
3.71; P<0.0001) were significantly associated with NAFLD. The use of tobacco, cocaine,
and cannabis were no longer significant in multivariable analyses.
Liver fibrosis
In univariate analyses for liver fibrosis (Table 3.2), food insecurity was
independently associated with increased odds for advanced fibrosis (OR: 2.57, 95% CI:
1.20, 5.52; P=0.02) and showed a trend in association with any liver fibrosis (OR: 1.56,
95% CI: 0.99, 2.47; P=0.06). Additionally, a trend was seen for a dose-response effect
between the severity of food insecurity and the risk for advanced fibrosis (P=0.08 for
trend). Marginal, low, and VLFS were associated with 1.81, 2.73, and 3.42 times the risk
for advanced liver fibrosis compared to full food security. Of the metabolic risk factors,
reduced HDL-C and insulin resistance determined with TyG index were significantly
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associated with any liver fibrosis. Hyperglycemia showed trends in association with any
fibrosis and advanced liver fibrosis (P<0.1). No other metabolic parameter was
significantly associated with liver fibrosis or advanced fibrosis. HIV and HCV infections
were significantly associated with increased odds for any liver fibrosis, but only HCV
was significantly associated with advanced fibrosis.
In multivariable analyses (Table 3.5), food insecurity (AOR: 1.65, 95% CI: 1.01,
2.72 ; P=0.048), HIV infection (AOR: 2.07, 95% CI: 1.25, 3.44; P=0.005), HCV
infection (AOR: 5.05, 95% CI: 3.07, 8.32; P<0.0001), hyperglycemia (AOR: 1.86, 95%
CI: 1.07, 3.22; P=0.03), and TyG index (AOR: 1.59, 95% CI: 1.09, 2.32; P=0.02) were
significantly associated with any fibrosis after adjustment for confounders. Food
insecurity was also associated with advanced fibrosis (AOR: 2.82, 95% CI: 1.22, 6.54;
P=0.02), as was HCV infection, but HIV infection and hyperglycemia were no longer
significant. No significant interaction effects were identified for liver fibrosis.
Furthermore, a sensitivity analysis excluding HCV-positive participants showed that food
insecurity remained significantly associated with advanced liver fibrosis (OR: 5.23, 95%
CI: 1.34, 20.48; P=0.02).

Discussion
This report describes a unique study using non-invasive, MR-based objective
measures of liver steatosis and fibrosis to determine whether food insecurity is associated
with biomarkers of liver disease among a cohort of low-income, minority, middle-aged
adults living with and without HIV and HCV infections. Food insecurity was associated
with NAFLD depending on BMI; food insecurity was associated with greater liver fat
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content only among obese participants. Food insecurity was also an independent risk
factor for liver fibrosis, particularly advanced fibrosis. Additionally, the risk for advanced
liver fibrosis correlated with the severity of food insecurity. These findings are highly
relevant for the food-insecure population, particularly those living with HIV and/or HCV
since they are already at increased risk of liver-related morbidity and mortality and suffer
from disproportionately high rates of food insecurity. However, our findings did not show
a cumulative effect of food insecurity and viral infections on liver disease, therefore
indicating that food insecurity may be a clinically relevant independent risk factor for
liver disease.
Nearly a third of our participants reported FI, which is consistent with the 29%
prevalence among U.S. households with incomes below 185% of the federal poverty
level 1. Using MRI-PDFF, our findings suggest a NAFLD prevalence of 16% within the
cohort. The low prevalence of NAFLD compared to 25-33% in the general U.S.
population11-13 might be related to the high proportion of Black non-Hispanic males in the
MASH cohort,8,11 as well as increased accuracy from MRI-PDFF compared to other noninvasive measures of liver steatosis.40
To the best of our knowledge, only one study has previously explored the
relationship between food insecurity and NAFLD. Using NHANES data, Golovaty et al.
estimated that 32% of U.S. adults living under 200% of the federal poverty level had
NAFLD and 5% had advanced fibrosis.16 Similar to our results, food insecurity was
associated with more than double the odds for advanced liver fibrosis, determined with
the NAFLD Fibrosis Score, a non-invasive index that does not provide a direct
measurement of fibrosis, but uses age, BMI, AST/ALT ratio, platelets, and albumin.48 In
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contrast to our findings, Golovaty et al. also found that food insecurity was independently
associated with increased odds of NAFLD using the U.S. Fatty Liver Index, also not a
direct measure, but an algorithm incorporating race/ethnicity, age, waist circumference,
glucose, and insulin levels.49 We have utilized MRE and MRI-PDFF, which represent
valid and highly reproducible measurements of liver stiffness and liver fat.39,40 In
addition, the participants in the Golovaty study were younger and had larger proportions
of females and White non-Hispanics. Further, many of the participants in our study used
tobacco, cocaine, or cannabis, all of which were significantly associated with decreased
odds for liver steatosis. We also observed trends towards higher rates of smoking and
cocaine use in food-insecure than food-secure participants, and VLFS was associated
with increased polysubstance use. Nicotine, cocaine, and cannabis may lead to lower
body weight through several mechanisms, including decreased appetite and altered
metabolism.50 By decreasing body adiposity, substance abuse may partially explain the
low prevalence of NAFLD in the cohort, as well as the decreased risk for NAFLD
associated with food insecurity among non-obese participants.
There are several potential explanations for the effects of food insecurity on liver
disease observed in this study. Food insecurity is associated with inadequate dietary
intakes, limited food choices, poor diet quality with low-cost, high-fat, high-sugar,
calorie-dense foods, and disrupted eating patterns that contribute to obesity 3,4. Moreover,
food insecurity often forces individuals to make tradeoffs between buying food or
obtaining medical care and medications.51,52 Consequently, food-insecure individuals are
at increased risk for metabolic conditions, such as obesity and type 2 diabetes 7, which
have bidirectional relationships with NAFLD.53,54 In this study, hyperglycemia and
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insulin resistance were associated with NAFLD and liver fibrosis. Food insecurity may
lead to poor glycemic control and insulin resistance by increased stress55,56 and poor
adherence to medical recommendations.57 Indeed, type 2 diabetes and its precursor,
insulin resistance, are key pathogenic mechanisms of NAFLD,58 promoting progression
to NASH, advanced liver fibrosis,59-61 hepatocellular carcinoma,62 and mortality.63,64
The strengths of the study include the large sample of participants with outcome
measures obtained with accurate, non-invasive MR technology, and a balanced study
design that included PLWH, people infected or co-infected with HCV, and uninfected
participants with similar sociodemographic characteristics. The use of MRI-PDFF and
MRE provides a high level of accuracy compared to other non-invasive tests.40 Several
limitations in this study should be noted. While the study included a large sample size,
the relatively low frequency of advanced liver fibrosis warrants caution in the
interpretation of the results. Alcohol consumption was self-reported, thus, subject to
underreporting. It is also possible that some of the effect of food insecurity on liver
fibrosis seen in this study may not be metabolic- or NAFLD-related; however, the
association between food insecurity and advanced liver fibrosis was significant while
controlling for and excluding HCV infection. Lastly, the cross-sectional design does not
allow for temporality to be established. Indeed, it is possible that the association between
food insecurity and liver fibrosis seen in this study may be related to reverse causation.
For example, HIV/HCV infection may result in liver fibrosis and lead to psychosocial
factors such as poverty and drug use, which then contribute to food insecurity.
Decompensated cirrhosis may also result in hepatic encephalopathy with behavioral
changes that contribute to FI; however, none of the participants in this study had
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decompensated cirrhosis. Therefore, longitudinal studies are needed to better comprehend
the potential role of food insecurity in the development and progression of liver diseases.
Our findings provide further evidence that food insecurity is a social determinant of
health that contributes to the prevalence of liver disease.16 The burden of NAFLD is only
expected to rise,65 and extrahepatic manifestations of NAFLD may promote the
development or aggravation of other chronic comorbidities.66 The fact that food
insecurity was independently associated with more than twice the risk for advanced liver
fibrosis is particularly relevant to clinical outcomes since fibrosis stage, not NASH,
predicts mortality in NAFLD patients.67
Conclusions
Among low-income, middle-aged minorities living with and without HIV and/or
HCV in the MASH cohort, food insecurity was associated with increased liver fat content
among obese participants and increased risk for advanced liver fibrosis. People who
experience FI, particularly those vulnerable to chronic diseases and viral infections, may
be at increased risk for advanced liver disease, which in turn is associated with greater
morbidity and mortality. Improving access to adequate nutrition and preventing obesity
among low-income groups in the United States may lessen the growing burden of
NAFLD and other metabolic chronic diseases.
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Table 3.1. Sample Characteristics by Food Security Status
Characteristics

Age, years
Gender
Race/ethnicity

Marital Status

Category

Male
Black non-Hispanic
White Hispanic
White non-Hispanic
Multiracial/other
Married
Widowed, divorced,
or separated
Single

Household size
Children in
Household
Education

Employment

Income

Poverty
Substance Use

Infection

Metabolic

Less than HighSchool
High-School or GED
Some College or
more
Employed
Disabled
Otherwise
unemployed
Less than $10,000
$10,000 - $20,000
$20,000 - $30,000
$30,000 or more
Below federal
poverty level
Tobacco
Alcohol, drinks/week
Cocaine
Cannabis
Opiates
HIV
ART
HIV viral load
< 200 copies/mL
CD4 (cells/mL)
HCV
BMI, kg/m2
Obese (BMI ≥ 30
kg/m2)

Total
N=603
N (%)
Mean ± SD
55.5 ± 6.2
338 (56.0)
366 (60.7)
130 (21.6)
55 (9.1)
52 (8.6)
64 (10.6)

Food-Secure
N=410
N (%)
Mean ± SD
55.6 ± 6.2
234 (57.1)
256 (62.4)
86 (21.0)
32 (7.8)
36 (8.8)
45 (11.0)

Food-Insecure
N=193
N (%)
Mean ± SD
55.2 ± 6.0
104 (53.9)
110 (57.0)
44 (22.8)
23 (11.9)
16 (8.3)
19 (9.8)

203 (33.7)

132 (32.2)

71 (36.6)

0.53

336 (55.7)
1.8 ± 1.3

233 (56.8)
1.8 ± 1.3

103 (53.4)
1.7 ± 1.2

0.46

50 (8.3)

32 (7.8)

18 (9.3)

0.53

240 (39.8)

169 (41.2)

71 (36.8)

173 (28.7)

109 (26.6)

64 (33.2)

190 (31.5)

132 (32.2)

58 (30.1)

76 (12.6)
310 (51.4)

59 (14.4)
202 (49.3)

17 (8.8)
108 (56.0)

217 (36.0)

149 (36.3)

68 (35.2)

336 (55.7)
164 (27.2)
56 (9.3)
47 (7.8)

213 (52.0)
118 (28.8)
38 (9.3)
41 (10.0)

123 (63.4)
46 (23.8)
18 (9.3)
6 (3.1)

0.01

462 (76.6)

303 (73.9)

159 (82.4)

0.02

298 (49.4)
0 (0, 1)1
225 (37.3)
166 (27.5)
64 (10.6)
263 (43.6)
259 (98.5)

193 (47.1)
0 (0, 1)1
143 (34.9)
108 (26.3)
43 (10.5)
185 (45.1)
183 (98.9)

105 (54.4)
1 (1, 2)1
82 (42.5)
58 (30.1)
21 (10.8)
78 (40.4)
76 (97.4)

0.09
0.45
0.07
0.34
0.89
0.28
0.58

222 (84.7)

160 (87.0)

62 (79.5)

0.12

597.8 ± 368.0
144 (23.9)
29.5 ± 6.1

610.5 ± 384.0
94 (22.9)
29.6 ± 6.2

566.6 ± 326.3
50 (25.9)
29.2 ± 6.0

0.42
0.42
0.55

250 (41.5)

174 (42.4)

76 (39.4)

0.48
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P1
0.39
0.46
0.35

0.24

0.11

Total
Food-Secure Food-Insecure
N=603
N=410
N=193
N (%)
N (%)
N (%)
Mean ± SD
Mean ± SD
Mean ± SD
MetS
127 (21.1)
89 (21.7)
38 (19.7)
Hyperglycemia
133 (22.1)
89 (21.7)
44 (22.8)
Hypertriglyceridemia 140 (23.2)
89 (21.7)
51 (26.4)
Hypertension
331 (54.9)
228 (55.6)
103 (53.4)
Reduced HDL-C
63 (10.5)
45 (11.0)
18 (9.3)
Abdominal obesity
317 (52.6)
210 (51.2)
107 (55.4)
TyG index
8.5 ± 0.6
8.5 ± 0.6
8.5 ± 0.6
Hepatic
ALT
18 (14, 27)2
19 (14, 27)2
18 (14, 27)2
2
2
AST
22 (17, 29)
22 (17, 29)
21 (17, 27)2
AST/ALT
1.23 ± 0.4
1.24 ± 0.4
1.22 ± 0.4
1
Tests for group differences performed with Chi-square test for categorical outcomes and T-test (or
Wilcoxon rank-sum) for continuous outcomes.
2
Median (interquartile range)
Abbreviations: ART- antiretroviral therapy; FS- food security; MetS- metabolic syndrome; TyGtriglyceride and glucose index
Characteristics

Category

114

P1
0.57
0.76
0.20
0.60
0.53
0.33
0.59
0.83
0.55
0.49

Table 3.2. Univariate Analyses for NAFLD (Liver Fat >5% via MRI-PDFF), Fibrosis (LS ≥2.9 kPa via MRE), and
Advanced Fibrosis (LS ≥3.8 kPa via MRE) (N=603)1
Parameter
Food Insecurity

Substance Use

Infection
Metabolic

Category

NAFLD (n=96)

Any Fibrosis (n=91)

Advanced Fibrosis (n=28)

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Food insecure vs secure

0.99 (0.62, 1.58)

0.97

1.56 (0.99, 2.47)

0.06

2.57 (1.20, 5.52)

0.02

Marginal vs. full security

0.92 (0.50, 1.70)

0.79

0.55 (0.18, 1.73)

0.31

1.81 (0.58, 5.65)

0.31

Low vs. full security

0.67 (0.33, 1.39)

0.29

1.51 (0.45, 5.13)

0.51

2.73 (0.92, 8.10)

0.07

Very low vs. full security

1.28 (0.73, 2.26)

0.39

1.89 (0.61, 5.85)

0.27

3.42 (1.29, 9.11)

0.01

Tobacco

0.47 (0.30, 0.74)

0.001

0.95 (0.61, 1.49)

0.83

0.76 (0.35, 1.63)

0.48

Alcohol (drinks/week)

1.03 (0.97, 1.09)

0.40

0.97 (0.91, 1.05)

0.45

1.01 (0.90, 1.12)

0.93

Cocaine

0.50 (0.30, 0.81)

0.006

0.85 (0.53, 1.35)

0.49

0.93 (0.42, 2.05)

0.86

Cannabis

0.51 (0.29, 0.88)

0.02

1.21 (0.74, 1.96)

0.45

0.87 (0.36, 2.09)

0.76

Opiates

0.84 (0.40, 1.76)

0.65

1.34 (0.69, 2.63)

0.39

1.43 (0.48, 4.26)

0.52

HIV

0.73 (0.47, 1.14)

0.16

1.71 (1.09, 2.68)

0.02

1.31 (0.61, 2.80)

0.49

HCV

0.81 (0.48, 1.38)

0.44

4.84 (3.03, 7.72)

<0.0001

13.62 (5.40, 34.32)

<0.0001

BMI, per 5 kg/m2

1.75 (1.46, 2.09)

<0.0001

0.90 (0.75, 1.09)

0.28

0.79 (0.56, 1.10)

0.16

Obesity

3.71 (2.33, 5.89)

<0.0001

0.82 (0.52, 1.29)

0.39

0.78 (0.35, 1.71)

0.53

MetS

3.95 (2.49, 6.28)

<0.0001

1.33 (0.79, 2.23)

0.29

1.02 (0.41, 2.58)

0.97

Hyperglycemia

2.92 (1.84, 4.63)

<0.0001

1.62 (0.98, 2.67)

0.06

2.04 (0.92, 4.54)

0.08

Hypertriglyceridemia

2.64 (1.67, 4.18)

<0.0001

0.99 (0.58, 1.68)

0.97

0.54 (0.18, 1.58)

0.26

Abdominal obesity

3.47 (2.11, 5.71)

<0.0001

0.82 (0.53, 1.28)

0.38

0.66 (0.31, 1.43)

0.29

Hypertension

1.41 (0.91, 2.20)

0.13

1.24 (0.79, 1.95)

0.36

1.10 (0.51, 2.37)

0.81

Reduced HDL-C

1.42 (0.74, 2.72)

0.28

1.91 (1.02, 3.58)

0.04

1.94 (0.71, 5.29)

0.19

TyG index
2.72 (1.95, 3.79) <0.0001 1.45 (1.03, 2.03) 0.03
1.28 (0.72, 2.26)
0.39
Statistical tests were performed using univariate logistic regressions and reported as odds ratio with 95% confidence interval (CI).Abbreviations: LSliver stiffness; MetS- metabolic syndrome; MRE- magnetic resonance elastography; MRI-PDFF- magnetic resonance imaging-derived measurement of
proton density fat fraction; NAFLD- nonalcoholic fatty liver disease; TyG- triglyceride and glucose index
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Table 3.3. Multivariable Analyses for NAFLD (Liver Fat >5%) Determined by
MRI-Determined Proton Density Fat Fraction (MRI-PDFF) (N=603)
Parameter

AOR (95% CI)1

P-value

Hyperglycemia

2.48 (1.46, 4.20)

0.0008

Hypertriglyceridemia

2.18 (1.29, 3.67)

0.004

2

3.20 (1.92, 5.32)

<0.0001

TyG index2

2.57 (1.78, 3.71)

<0.0001

Alcohol, drinks/week

1.06 (0.99, 1.13)

0.08

MetS

Parameter
BMI, per 5 kg/m

Food insecurity

2

1

Condition

AOR (95% CI)

x Food insecurity

(interaction)

<0.0001

Food-secure:
Food-insecure:
BMI=25.0

1.32 (1.04, 1.67)
3.83 (2.37, 6.19)

0.02
<0.0001

0.20 (0.07, 0.57)

0.002

BMI=30.0

0.59 (0.31, 1.14)

0.12

1.91 (1.02, 3.59)

0.04

(interaction)

0.003

0.30 (0.11, 0.83)

0.02

BMI=35.0
x Obesity (BMI ≥30)
Non-obese:

3

Obese:

P-value

1.85 (0.98, 3.53) 0.06
The multivariable logistic regression model examined the relationship between food insecurity, BMI, and
NAFLD adjusting for age, sex, race/ethnicity, household size, hyperglycemia, hypertriglyceridemia, and
included an interaction term for food insecurity and BMI. Estimates for the effect of food insecurity on
NAFLD were obtained for BMIs of 25, 30, and 35 kg/m2, which correspond to the cutoffs for overweight,
obesity class I, and obesity class II, respectively.
2
Due to multicollinearity, separate models were used to obtain estimates for MetS and TyG adjusting for
age, sex, race/ethnicity, household size, BMI, alcohol consumption, and food insecurity.
3
The multivariable logistic regression model examined the relationship between food insecurity and
NAFLD among obese and non-obese participants, adjusting for age, sex, race/ethnicity, household size,
hyperglycemia, hypertriglyceridemia, and included obesity (BMI ≥30 kg/m2) as well as an interaction term
for food insecurity and obesity.
Abbreviations: AOR- adjusted odds ratio; LFS- low food security; MetS- metabolic syndrome; TyGtriglyceride and glucose index, VLFS- very low food security
1
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Table 3.4. Multivariable Analyses for Any Liver Fibrosis (LS ≥2.9 kPa) and
Advanced Liver Fibrosis (LS ≥3.8 kPa) Determined by Magnetic Resonance
Elastography (MRE) (N=603)
Parameter

Any Fibrosis1

Advanced Fibrosis2

AOR (95% CI)

P-value

AOR (95% CI)

P-value

HIV

2.07 (1.25, 3.44)

0.005

1.79 (0.73, 4.40)

0.20

HCV

5.05 (3.07, 8.32)

<0.0001

1.86 (1.07, 3.22)

0.03

1.59 (1.09, 2.32)

0.02

12.56 (4.83, 32.64)
-

<0.0001
-

Hyperglycemia
TyG index

3

Alcohol, drinks/week 0.99 (0.92, 1.06) 0.69
1.00 (0.73, 1.11)
0.95
Food insecurity
1.65 (1.01, 2.72) 0.048
2.82 (1.22, 6.54)
0.02
1
The multivariable logistic regression model examined the relationship between food insecurity and any
liver fibrosis adjusting for age, sex, race/ethnicity, household size, HIV and HCV infections,
hyperglycemia, and alcohol consumption.
2
The multivariable logistic regression model examined the relationship between food insecurity and
advanced liver fibrosis adjusting for age, sex, race/ethnicity, household size, HIV and HCV infections, and
alcohol consumption.
3
Due to multicollinearity, a separate model was used to obtain estimates for TyG adjusting for age, sex,
race/ethnicity, household size, alcohol consumption, and food insecurity.
Abbreviations: AOR- adjusted odds ratio; MetS- metabolic syndrome; TyG- triglyceride and glucose index
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Figure 3.2. Comparison of Liver Parameters by Food Security Status. Of the 603 MASH cohort
participants, 97 (16.1%) had nonalcoholic fatty liver, 91 (15.1%) had liver fibrosis, and 28 (4.6%) had
advanced fibrosis. Liver fat content was assessed via magnetic resonance imaging-derived measurement of
proton density fat fraction (MRI-PDFF). Liver fibrosis was assessed via liver stiffness (LS) measurement
by magnetic resonance elastography (MRE). These were conducted on a 3T Siemens MAGNETOM Prisma
scanner. Nonalcoholic fatty liver was considered present if MRI-PDFF >5%. Liver fibrosis was defined as
LS ≥2.9 kPa, which is consistent with liver fibrosis stage 1 or higher, and advanced fibrosis was defined as
LS ≥3.8 kPa, consistent with liver fibrosis stage 3 or higher. Chi-square tests were performed to test for
differences between food-secure and food-insecure participants. * P<0.05; ^ P<0.1
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Figure 3.3. Predicted Probability Plot for NAFLD by BMI in Food-Secure vs. Food-Insecure. A
multivariable logistic regression model was used to examine the relationship between food insecurity and
NAFLD adjusting for age, sex, race/ethnicity, household size, hyperglycemia, hypertriglyceridemia, and
included BMI as well as an interaction term for food insecurity and BMI (see Table 3.3). There was a
significant interaction effect between food insecurity and BMI (P<0.0001). In other words, the effect of
food insecurity on NAFLD was dependent on BMI and vice versa. Estimates for the effect of food
insecurity on NAFLD were obtained for BMIs of 25, 30, and 35 kg/m2, which correspond to the cutoffs for
overweight, obesity class I, and obesity class II, respectively. For every 5-unit increase in BMI, the odds of
NAFLD were 3.83 (95% CI: 2.37, 6.19; P<0.0001) times higher in food-insecure participants (solid line)
compared to 1.32 (95% CI: 1.04, 1.67; P=0.02) times higher in food-secure participants (dotted line).
Likewise, compared to food-secure participants, the odds for NAFLD in food-insecure participants were: a)
0.20 (95% CI: 0.07, 0.57) at 25.0 kg/m2, b) 0.59 (95% CI: 0.31, 1.14) at 30.0 kg/m2, and c) 1.91 (95% CI:
1.02, 3.59) at 35.0 kg/m2. Abbreviations: FI- food insecurity; NAFLD- nonalcoholic fatty liver disease
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CHAPTER IV: ASSOCIATION OF FOOD INSECURITY WITH COGNITIVE
IMPAIRMENT 2
Abstract
Background: Food insecurity is a social determinant of health associated with cognitive
impairments in older adults and people living with HIV (PLWH). Few studies have
examined this relationship longitudinally, and no studies have explored how the
frequency of food insecurity over time may impact cognitive impairment.
Objective: To examine the impact of food insecurity on cognitive impairment over a 2year follow-up period in a cohort of people living with and without HIV.
Methods: Two-year longitudinal analysis of primarily economically disadvantaged,
middle-aged, Black, and Hispanic participants from the Miami Adult Studies on HIV
(MASH) cohort. Food insecurity was assessed with the USDA Household Food Security
Module at baseline, 12- and 24-month follow-ups. Food insecurity in all three
assessments was considered persistent food insecurity. Cognitive impairment was
assessed with the Mini-Mental State Examination (MMSE). Statistical analyses consisted
of logistic regressions.
Results: A total of 394 participants (247 HIV+) with 2-year follow-up data were
included in this analysis. At baseline, 104 (26.4%) were food-insecure and 58 (14.7%)
had cognitive impairment. Very low food security was associated with cognitive
impairment at baseline (OR: 3.23, 95% CI: 1.08−9.65). PLWH not virally suppressed had

2

Reprinted from: Tamargo JA, Meade CS, Campa A, Martinez SS, Li T, Sherman KE, Baum MK. Food
Insecurity and Cognitive Impairment in the Miami Adult Studies on HIV (MASH) Cohort. J Nutr. 2021.
doi:10.1093/jn/nxaa416
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higher risk for cognitive impairment compared to HIV-uninfected participants (OR: 2.87,
95% CI: 1.15−7.18). Additionally, baseline food insecurity (OR: 2.28, 95% CI:
1.08−4.81) and the frequency of food insecurity over time (OR: 1.50 per year, 95% CI:
1.08−2.10), particularly persistent food insecurity (OR: 3.69, 95% CI: 1.15−11.83), were
associated with cognitive impairment at 2-year follow-up; the results were consistent
after excluding cognitively impaired participants at baseline.
Conclusions: Food insecurity is a significant risk factor for cognitive impairment,
particularly among individuals who experience food insecurity frequently or persistently.
Screening for food insecurity and interventions to secure access to sufficient, nutritious
foods may help delay cognitive decline among socioeconomically disadvantaged
individuals.

Introduction
Food insecurity (FI) refers to a lack of dependable access to sufficient and
nutritious food for an active and healthy life. Food insecurity is the result of limited
resources and is associated with poverty, unemployment, and high housing costs.1 As
such, food insecurity is a socioeconomic condition that impacts 14.3 million (11.1%)
households in the United States.2 It is often episodic, triggered by unemployment,
inflation, food prices, or unforeseen costs.3,4 Yet, for many households, food insecurity is
a frequent or persistent problem that occurs for an average of 7 months out of the year.5
Tightly related to sociodemographic factors, food insecurity is disproportionately
prevalent among minorities6 and other marginalized groups, including people living with
HIV (PLWH).7,8
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In the United States, adults from food-insecure households are at increased risk for
chronic diseases and mental health conditions.9,10 Food insecurity has been associated
with cognitive deficits among U.S. older adults.11-13 Fewer studies have examined this
association among middle-aged adults, but Wong et al. showed an association between
very low food security (VLFS) and cognitive decline among U.S. adults aged 40-75
years.14 Furthermore, neurocognitive disorders are found in approximately 20-50% of
PLWH15 and persist despite long-term viral suppression.16 We have previously shown
that VLFS was associated with poorer mental health quality of life in PLWH.17 Hobkirk
et al. showed that food insecurity was associated with cognitive impairments among
PLWH but not HIV-uninfected participants.18 Although the findings are generally
consistent, the existing evidence is limited by heterogeneity in samples, food insecurity
measures, and time frames.19 Few longitudinal studies are available, and none have
applied repeated food insecurity measurements to determine the effects of frequency and
duration of food insecurity on cognitive impairment.
Food insecurity and HIV are thought to have a bidirectional relationship, as living
with HIV reinforces food insecurity and, in turn, food insecurity may promote
immunodeficiency and HIV disease progression.20,21 Indeed, food insecurity is associated
with poorer adherence to antiretroviral therapy (ART), lower odds for viral suppression,
and lower CD4 cell counts in PLWH.22-24 Moreover, PLWH have increased nutritional
needs, particularly as the HIV disease progresses.25,26 Food insecurity can contribute to
inflammation in PLWH,27 a key mechanism in HIV-associated neurocognitive
disorders.28 Therefore, via behavioral and biological mechanisms alike, food insecurity
has the potential of contributing to or exacerbating cognitive dysfunction in PLWH.
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To the best of our knowledge, no studies have examined the longitudinal
relationship between food insecurity and cognitive impairment among people living with
and without HIV, considering the impact of the frequency of food insecurity over time.
The aim of this study was to determine whether food insecurity is associated with
cognitive impairment cross-sectionally and after a 2-year follow-up. We hypothesized
that (1) food insecurity would be independently associated with increased risk for
cognitive impairment, (2) the risk for cognitive impairment would correlate with the
severity and frequency of food insecurity, and (3) the relationship between food
insecurity and cognitive impairment would be stronger among PLWH than HIVuninfected persons.

Methods
This was a longitudinal analysis of data collected between October 2016 and
February 2020 from the ongoing Miami Adult Studies on HIV (MASH) cohort (NIDA
grant # U01-DA040381). Participants are ≥40 years of age, hepatitis B negative, and have
documented HIV and hepatitis C virus (HCV) status (positive or negative). For this
analysis, we used data collected at baseline, 12- and 24-month follow-ups, excluding
participants who were unable to complete cognitive testing (e.g., unable to read or write,
n=20) or were missing crucial data (n=9). All participants provided written consent for
participation in this study and release of medical records. The protocol for this study was
approved by the Florida International University Institutional Review Board.
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Food security status
Food insecurity was determined with the Household Food Security Module, which
assesses a respondent’s perceived food sufficiency and adequacy during the past 12
months.29 Based on the number of affirmative responses, participants were classified as
food-secure (score 0−2) or food-insecure (score ≥3). Food insecurity was further explored
by levels of severity: full (score of 0), marginal (score of 1−2), low (score of 3−7 for
households with children and 3−5 without children), and VLFS (score ≥8 with children
and ≥6 without children). Additionally, we examined the frequency of food insecurity
over the 2-year period by using the total sum of time-points with self-reported food
insecurity. Food insecurity was measured at baseline and 12- and 24-month follow-ups,
thus participants could report food insecurity up to 3 times, equivalent to 3 years of food
insecurity. Reporting food insecurity at all times was considered persistent food
insecurity.
Cognitive function
Cognitive function was assessed with the Mini-Mental State Examination (MMSE),
using scores ≤24 out of 30 as cutoff for impairment.30 The MMSE is a measure of global
cognitive function and the most widely used screening tool for cognitive impairment,
with sensitivity and specificity of 81% and 89%, respectively, for the detection of
dementia.31
Additional covariates
Food insecurity has been associated with several conditions that may have an
impact on cognitive function, including obesity, diabetes,9,10 liver disease,32 and mental
health problems, such as depression9 and substance abuse.33-36 Therefore, we considered
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these risk factors as potential confounders. Sociodemographic characteristics were selfreported. Substance use was determined by self-report (past 30-days) and urine
toxicology (American Bio Medica, Kinderhook, NY, USA). Hazardous alcohol
consumption was determined with scores ≥8 in the Alcohol Use Disorders Identification
Test (AUDIT).37 Anthropometric measurements, vital signs, and fasting blood samples
were obtained in all study visits. Obesity was defined as a body mass index (BMI) ≥30
kg/m2, hyperglycemia as fasting blood glucose ≥100 mg/dL, and hypertension as ≥130
mm Hg systolic or ≥85 mm Hg diastolic blood pressure. Liver fibrosis was determined
with the Fibrosis-4 Index (FIB-4), using a cutoff of 1.45.38 Depression symptomatology
was assessed with the Center for Epidemiological Studies–Depression Scale (CES-D),
with scores ≥16 used to classify the presence of depressive symptoms.39 HIV viral loads
and CD4 cell counts were obtained from medical records. HIV viral suppression was
defined as having a plasma HIV RNA <200 copies/mL.
Statistical analyses
Descriptive statistics consisted of Chi-square tests for categorical variables and Ttests or one-way ANOVA for continuous variables, reported as No. (%) or mean ±
standard deviation (SD). Comparison of distributions between baseline and 2-year
follow-up consisted of paired-sample T-test and McNemar’s test for continuous and
categorical variables, respectively. The primary exposure of interest was food insecurity,
and the primary outcome was cognitive impairment. Separate models were used to
examine food insecurity by levels of severity: (1) using the traditional classification of
food insecurity (low and very low food security) vs. food secure (full and marginal food
security), (2) comparing marginal-to-very low food security to full food security, and (3)
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comparing each of marginal, low, and very low food security to full food security. First, a
cross-sectional analysis consisted of binary logistic regressions for cognitive impairment
at baseline. Second, we performed binary logistic regressions for cognitive impairment at
2-year follow-up, controlling for baseline MMSE scores. In these analyses, we tested the
effect of food insecurity at baseline and the effect of the frequency of food insecurity. We
additionally performed multivariable regressions adjusting for sociodemographic
characteristics (sex, race/ethnicity, income, household size), depressive symptoms,
obesity, hyperglycemia, hypertension, liver fibrosis, and HIV and HCV infections. We
tested for interaction effects between food insecurity and covariates; these were removed
from models if nonsignificant. Results are reported as odds ratios (OR) and 95%
confidence intervals (CI) and considered statistically significant at P<0.05, two-tailed.
The data analysis for this paper was generated using SAS software, version 9.4.
Copyright © 2002-2012 SAS Institute Inc., Cary, NC, USA.

Results
Population Characteristics
A total of 394 participants with 24-month follow-up data were included in this
analysis. In the ongoing MASH cohort, the overall loss to follow-up has been 3% per
year. The study population, as shown in Table 4.1, was largely comprised of
economically disadvantaged (all below 200% of the federal poverty level), middle-aged,
Black, and Hispanic individuals. At baseline, 104 (26.4%) participants were foodinsecure, with low and VLFS in 52 (13.2%) and 52 (13.2%), respectively. An additional
64 (16.2%) participants reported marginal food security. At 2-year follow-up, 104
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(26.4%) were food-insecure, with marginal, low and VLFS in 35 (8.9%), 50 (12.7%) and
54 (13.7%), respectively. Compared to food-secure participants, those who reported food
insecurity had fewer household members (P=0.003), were more likely to use cocaine
(P=0.002), and to report depressive symptoms (63.5 vs. 32.1%; P<0.0001). No
differences were observed on metabolic parameters (BMI, obesity, hyperglycemia, and
hypertension) or liver fibrosis. A comparison of sample characteristics by levels of food
insecurity can be found in Table 4.2.
Food insecure participants tended to be less likely to be infected with HIV than
food secure participants (54.8 vs. 65.5%, respectively; P=0.053); conversely, fewer
PLWH tended to report food insecurity than HIV-uninfected participants (23.1 vs. 32.0%,
respectively; P=0.053). Of the 247 (62.7%) PLWH, 246 (99.6%) were receiving ART
and 214 (86.6%) were virally suppressed. Also, 43 (10.9%) participants were infected
with HCV, including 21 (5.3%) who were coinfected with both HIV and HCV. No
participants acquired HIV or HCV infection throughout the study period.
Prevalence of cognitive impairment
At baseline, 58 (14.7%) participants had cognitive impairment, including 39 foodsecure and 19 food-insecure participants. At 2-year follow-up, 49 (12.4%) participants
had cognitive impairment, including 20 participants who did not have cognitive
impairment at baseline. However, overall, there was no significant change in MMSE
scores (t(393)=1.89, P=0.06) or in the frequency of cognitive impairment (χ2(1)=1.65,
P=0.20) between baseline and 2-year follow-up.
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Cognitive impairment at baseline
Table 4.3 shows the results of logistic regressions for cognitive impairment at
baseline. Overall, food insecurity was not associated with cognitive impairment.
However, compared to full food security, VLFS was associated with 3.23 (95% CI:
1.08−9.65; P=0.04) times the risk for cognitive impairment. Similar results were obtained
after adjusting for covariates.
In addition to these results, hypertension was associated with increased risk for
cognitive impairment (OR=1.80, 95% CI: 1.01−3.22; P=0.048) and there was a marginal
association with liver fibrosis (OR=1.67, 95% CI: 0.93−2.99; P=0.08). Depressive
symptoms (OR=1.35, 95% CI: 0.77−2.36; P=0.3), BMI (OR=0.99, 95% CI: 0.95−1.03;
P=0.7), obesity (OR=0.94, 95% CI: 0.54−1.65; P=0.8), hyperglycemia (OR=0.67, 95%
CI: 0.32−1.38; P=0.3), HIV (OR=1.52, 95% CI: 0.83−2.79; P=0.2) and HCV (OR=1.63,
95% CI: 0.74−3.61: P=0.2) were not significantly associated with cognitive impairment.
On the other hand, the risk for impairment was significantly higher among PLWH who
were not virally suppressed (OR: 2.87, 95% CI: 1.15−7.18; P=0.02) compared to HIVuninfected participants.
Cognitive impairment at 2-year follow-up
We performed logistic regression for cognitive impairment at 2-year follow-up,
controlling for MMSE scores at baseline (Table 4.4). Baseline food insecurity was
associated with cognitive impairment at 2-year follow-up (OR=2.28, 95% CI: 1.08−4.81;
P=0.03). The association was also significant when comparing marginal-to-VLFS to full
food security (OR=2.47, 95% CI: 1.2−5.10; P=0.01). Additionally, for every instance that
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participants reported food insecurity in the past 12-months (range: 0 to 3 years for food
insecurity at baseline and at 12- and 24-month follow-ups), the odds for cognitive
impairment at follow-up increased one and a half times (95% CI: 1.08−2.10; P=0.02). In
particular, persistent food insecurity − reporting food insecurity throughout the entire
study − was significantly associated with increased risk for cognitive impairment
compared to those who never reported food insecurity (OR: 4.18, 95% CI: 1.29−13.59;
P=0.02). These relationships remained significant in the fully adjusted multivariable
model. None of the covariates were significantly associated with cognitive impairment at
2-year follow-up.
To validate these findings, we repeated the analysis among participants who were
not cognitively impaired at baseline (N=336), shown in Table 5.5. The results remained
consistent. Baseline food insecurity was associated with 2.32 (95% CI: 0.91−5.93;
P=0.08) times the odds for cognitive impairment. Likewise, having marginal-to-VLFS
was significantly associated with increased risk for cognitive impairment at 2-year follow
up compared to full food security (OR=4.24, 95% CI: 1.48−12.10; P=0.007). The
frequency of food insecurity was associated with 1.53 (95% CI: 1.01−2.32; P=0.047)
times the odds for impairment for every year that participants experienced FI, and
persistent food insecurity was associated with 4.14 (95% CI: 1.09−15.70; P=0.04) times
the odds for impairment compared to no food insecurity.
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Discussion
This study of the MASH cohort found that food insecurity is a predictor of
cognitive impairment, both at baseline and after a 2-year follow-up. This is the food
insecurity study to establish an association between the frequency of food insecurity,
particularly persistent FI, and cognitive decline over time. Furthermore, our findings
suggest that even marginal food security is a risk factor for cognitive decline, despite it
being traditionally classified as food secure. Food insecurity was also associated with
depressive symptoms and cocaine use, but these did not seem to affect cognitive
impairment in this study. While food insecurity did not show an impact on HIV treatment
and viral load, PLWH who were not virally suppressed showed an increased risk for
cognitive impairment at baseline compared to HIV-uninfected individuals. These findings
are highly relevant, as food insecurity is intrinsically linked to mental health and
substance abuse,40 and can promote depression9 and HIV disease progression.23,24 It is
possible that these factors, when compounded, may have additive or exponential effects
on cognitive outcomes.
Both at baseline and at 2-year follow-up, VLFS more than tripled the odds for
cognitive impairment compared to full food security. This finding is similar to those
previously reported among homeless older adults41 and middle-to-older aged Hispanics.42
Two studies have also reported associations between food insecurity and cognitive
impairment using NHANES data from older adults.11,13 Studies that have performed
cognitive batteries suggest that food insecurity mostly affects executive functions, such as
processing speed, sustained attention, verbal fluency, working memory, and immediate
learning ability.13,14,42
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Over the course of 2-years, 20 participants developed cognitive impairment, but the
overall prevalence of cognitive impairment in the sample did not change. This may be
due to fluctuations in cognitive function as seen in dementia43,44 and HIV-associated
neurocognitive disorders.45 Nonetheless, similar to the findings in an HIV-uninfected
cohort by Wong et al.,14 food insecurity at baseline was associated with cognitive
impairment at 2-year follow-up and the greatest impact was seen in association with
VLFS. However, we also found that any level of food insecurity at baseline, including
marginal food security, was associated with cognitive impairment at follow-up.
Moreover, when we excluded participants with cognitive impairment at baseline, even
marginal food security was independently associated with cognitive impairment at
follow-up compared to full food security. To the best of our knowledge, we are the first
to show this association. Additionally, we are the first to show an association between the
frequency of FI, particularly persistent FI, and cognitive impairment; those who
consistently experienced food insecurity (reporting past 12-month food insecurity at
baseline and at the two yearly follow-ups; equivalent to 3 years of FI) had the highest risk
for cognitive impairment at 2-year follow-up. In the Women's Interagency HIV Study,
persistent food insecurity (defined as two consecutive 6-month intervals of FI) was
associated with increased risk for depression and poor mental well-being.46
Despite the high prevalence of food insecurity and cognitive impairments among
PLWH, only two cross-sectional studies have previously examined how food insecurity
may contribute to cognitive impairment in PLWH. Using the Montreal Cognitive
Assessment (MoCA), Hessol et al. were unable to find a significant association between
food insecurity and cognitive impairment, possibly related to the high prevalence of

131

impairment in that sample.47 In contrast, Hobkirk et al. found a significant interaction
effect between HIV and food insecurity on the neurocognitive performance of 61 PLWH
and 36 HIV-uninfected middle-aged adults.18 Among PLWH, food insecurity was
associated with significantly higher deficits in the domains of speed of information
processing, learning, and motor function, but not memory. There were no significant
differences in domain deficit scores among HIV-uninfected participants, possibly due to
the small sample. Our findings support the hypothesis that food insecurity may promote
cognitive impairment in PLWH independent of adherence to ART and HIV viral load,
but we were unable to detect a differential effect between those living with or without
HIV possibly due to the vast majority (87%) being virally suppressed. Nonetheless, in
our study, PLWH who were not virally suppressed were at a significantly increased risk
for cognitive impairment than HIV-uninfected participants. More sensitive
neurocognitive testing, such as that performed by Hobkirk et al., with larger sample sizes
may be able to identify HIV-associated neurocognitive dysfunctions altered by food
insecurity.
Interestingly, food insecurity was associated with depressive symptoms and
cocaine use, which can contribute to cognitive dysfunction.48,49 Notably, 40% of all
participants, including 64% of food-insecure participants in this study reported depressive
symptoms, which suggests a markedly higher prevalence of depression in this cohort than
seen in other U.S. population-based studies of food-insecure individuals.50,51 It is possible
that compounding factors in this population, such as minority status, poverty, FI, chronic
disease burden, substance use disorders, and HIV-related stigma, among others, may
contribute to the high prevalence of depressive symptoms in this vulnerable population.
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Additionally, food insecurity was associated with cocaine use, which has been associated
with impaired processing speed and executive functioning.52 Chronic substance abuse can
lead to long-lasting cognitive impairments49 and may have significant interactions with
food insecurity and mental health.40 For example, cocaine use may contribute to food
insecurity by affecting impulse control and reward-based decision making.53
Interestingly, neurocognitive impairment may play a role in poorer ART adherence
among PLWH who use cocaine,54 thereby furthering the risk for cognitive dysfunction.
It is worth mentioning that while in this study food insecurity was not associated
with liver fibrosis (measured with the FIB-4 Index), this association has been made by
Golovaty et al. using NHANES data.32 We have also found food insecurity to be
associated with advanced liver fibrosis when measured with magnetic resonance
elastography;55 however, this assessment was not available for all the participants in this
analysis. In this study, we observed a trend for liver fibrosis in association with cognitive
impairment. Notably, liver disease is a major cause of morbidity and mortality in
PLWH56 and has been associated with cognitive impairments in PLWH.57,58
Although the exact mechanisms remain unknown, there are several potential ways
by which food insecurity may contribute to cognitive impairment. In resource-rich
settings, food insecurity is associated with maladaptive eating behaviors and poor diet
quality, although overall energy intake may not be affected.59 Consequently, food
insecurity may result in deficiencies of essential nutrients for brain and cognitive
function, such as B-vitamins and n-3 polyunsaturated fatty acids, as well as dietary
patterns that promote neuroinflammatory processes.60,61 Our finding that persistent food
insecurity was associated with cognitive decline, for example, may be due in part to long-
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term nutritional inadequacies. A “neuroprotective dietary pattern,” consisting of
antioxidant- and polyphenol-rich foods including fruits, vegetables, monounsaturated
fats, and n-3 fatty acids (i.e., Mediterranean diet),61,62 may be inaccessible to people who
experience food insecurity. Food insecurity can also contribute to cognitive dysfunction
through comorbidities directly affected by diet, such as cardiovascular disease and
diabetes. These conditions may be aggravated by poor disease self-management as a
result of monetary constraints, such as having to choose between food or medication. Our
findings related to food insecurity persistence may be particularly relevant, as persistent
food insecurity has been associated with increased cost-related medication non-adherence
among older adults.63 Interestingly, food insecurity has also been associated with shorter
leukocyte telomere length in U.S. adults ages 25−45 years, suggesting that food
insecurity may advance aging.64
Nevertheless, food insecurity is a modifiable risk factor for cognitive impairment.
Thus, improving access to sufficient nutritious foods and improving dietary patterns
among economically disadvantaged households may allow for lifestyle changes that
improve nutritional status and reduce comorbidities, ultimately delaying cognitive
decline. In the United States, several food-assistance programs have been implemented to
reduce FI, the largest of which is the Supplemental Nutrition Assistance Program
(SNAP), also known as food stamps. Although most eligible individuals participate in the
program (84% in 2017),65 many SNAP recipients remain food-insecure even after
receiving benefits, as these are often insufficient to relieve monetary constraints.66
Furthermore, the current criteria for eligibility prevent many individuals from obtaining
SNAP benefits.67 Therefore, there is a need for improved interventions to secure access to
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sufficient nutritious foods among socioeconomically disadvantaged groups. Given the
consistent findings linking food insecurity to cognitive function, food assistance
programs should account for cognitive impairments when planning benefits. Indeed,
cognitive impairment has the potential to exacerbate food insecurity by decreasing
functional abilities,68 thereby limiting work opportunities and income, the ability to
navigate processes to apply for food assistance programs, and the ability for disease selfmanagement. However, the effect of cognitive impairments on food security status is an
interesting area for future research that has not yet been explored.
Limitations of this study include the use of MMSE, a screener that has low
sensitivity for identifying mild HIV-associated cognitive disorder. However, in light of
our findings, food insecurity may be a clinically relevant risk factor for severe cognitive
impairments and dementia. Longitudinal studies using more sensitive neuropsychological
batteries and repeated measures of food security will help further our understanding of
the long-term effects of FI, including its severity, frequency, and persistence, on
cognitive decline. Neuroimaging studies are needed to identify specific brain structures
altered by food insecurity. Potential mediators, such as dietary patterns, vascular risk
factors, psychiatric comorbidities, and chronic stress should be examined.
Conclusion
Food insecurity is a significant risk factor for cognitive impairment, particularly
among individuals who experience food insecurity frequently or persistently. Attention
should be paid to PLWH, a population that is disproportionately affected by food
insecurity and cognitive dysfunction. Screening for food insecurity and interventions to
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secure access to sufficient nutritious foods may help delay cognitive decline among
socioeconomically disadvantaged individuals.
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Table 4.1. Population Characteristics at Baseline
Parameter
Age, years
Sex (male)
Race/ethnicity

Total1
(N=394)
53.9 ± 7.9
211 (53.6)

Food-secure1
(N=290)
53.9 ± 8.1
155 (53.5)

Food-insecure1
(N=104)
54.2 ± 7.0
56 (53.9)

P-value2
0.72
0.94

Black non-Hispanic 283 (71.8)
218 (75.2)
65 (62.5)
White Hispanic 55 (14.0)
37 (12.8)
18 (17.3)
0.07
White non-Hispanic
25 (6.4)
17 (5.9)
8 (7.7)
Multiracial/other
31 (7.9)
18 (6.2)
13 (12.5)
Income (below poverty)
309 (78.4)
227 (78.3)
82 (78.9)
0.90
Household size
1.9 ± 1.3
2.0 ± 1.4
1.6 ± 1.0
0.003
Education
Less than High-School 175 (44.4)
131 (45.2)
44 (42.3)
High-School or GED 12 (31.7)
92 (31.7)
33 (31.7)
0.82
More than High-School 94 (23.9)
67 (23.1)
27 (26.0)
Substances
AUDIT >8 100 (25.4)
72 (24.8)
28 (26.9)
0.67
Smoker (tobacco) 212 (53.8)
151 (52.1)
61 (58.7)
0.25
Cannabis 119 (30.2)
84 (29.0)
35 (33.7)
0.37
Cocaine 159 (40.4)
104 (35.9)
55 (52.9)
0.002
Opioids 40 (10.2)
27 (9.3)
13 (12.5)
0.36
Metabolic
BMI, kg/m2 30.0 ± 7.1
30.1 ± 7.3
29.7 ± 6.3
0.65
Obesity 175 (44.4)
129 (44.5)
46 (44.2)
0.96
Hyperglycemia 90 (22.8)
66 (22.8)
24 (23.1)
0.95
Hypertension 210 (53.4)
151 (52.3)
59 (56.7)
0.43
Hepatic
Liver fibrosis (FIB-4>1.45) 112 (28.4)
82 (29.3)
30 (28.9)
0.91
HIV
247 (62.7)
190 (65.5)
57 (54.8)
0.053
On ART 246 (99.6)
190 (100.0)
56 (98.3)
0.07
<200 copies/mL 214 (86.6)
168 (88.4)
46 (80.7)
0.13
CD4 cells/mL3 602 ± 343
605 ± 352
593 ± 315
0.82
HCV
43 (10.9)
31 (10.7)
12 (11.5)
0.81
HIV/HCV coinfection
21 (5.3)
15 (5.2)
6 (5.8)
0.82
Depressive symptoms (CES-D >16) 159 (40.4)
93 (32.1)
66 (63.5)
<0.0001
Abbreviations: ART, antiretroviral therapy; CES-D, Center for Epidemiological Studies–Depression Scale
1
Values are n (%) or mean ± SD
2
Chi-square tests for categorical factors and T-test for continuous factors
3
CD4 cell count data on n=232
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Table 4.2. Logistic Regressions for Cognitive Impairment (MMSE ≤24) at Baseline
(N=394)
Food insecurity2

Crude OR (95%
CI)
1.59 (0.85−2.97)

Pvalue
0.15

Full vs. marginal, low,
and
very low food security

1.11 (0.63−1.95)

0.72

Model

Parameter

1
2

Adjusted OR (95%
CI)1
1.56 (0.78−3.14)

1.05 (0.56−1.98)

Pvalue
0.21

0.89

3

Levels of food security
Full
Reference
Reference
1.47 (0.59−3.65)
1.59 (0.61−4.14)
Marginal
0.41
0.34
1.45 (0.47−4.50)
1.29 (0.39−4.32)
Low
0.52
0.68
3.23 (1.08−9.65)
4.16 (1.28−13.55)
Very low
0.04
0.02
1
Adjusted for age, years of education, race/ethnicity, sex, income, household size, obesity, hyperglycemia,
hypertension, depressive symptoms, liver fibrosis, and HIV/HCV infection
2
Food insecure (low and very low food security) vs. food secure (full and marginal food security)

Table 4.3. Logistic Regressions for Cognitive Impairment (MMSE ≤24) at 2-Year
Follow-Up (N=394)
0.03

Adjusted OR (95%
CI)2
4.21 (1.66−10.68)

0.002

2.47 (1.20−5.10)

0.01

4.41 (1.88−10.35)

0.001

Reference
2.01 (0.86−4.70)
2.80 (1.21−6.49)
3.02 (1.23−7.41)

0.11
0.02
0.02

Reference
2.31 (0.92−5.80)
3.34 (1.32−8.43)
4.62 (1.67−12.80)

0.08
0.01
0.003

1.50 (1.08−2.10)

0.02

1.85 (1.23−2.77)

0.003

Reference
1.62 (0.61−4.30)
2.10 (0.85−5.16)
3.69
(1.15−11.83)

0.33
0.11

Reference
2.37 (0.82−6.89)
3.23 (1.06−9.86)

0.11
0.04

0.03

6.77 (1.72−26.68)

0.006

OR (95% CI)1

P

Food insecurity at baseline3

2.28 (1.08−4.81)

2

Full vs. marginal, low, and
very low food security at
baseline

3

Levels of food security at
baseline

Model

Category

1

Full
Marginal
Low
Very low
4
5

Frequency of FI, per year
0 years of FI
1 year of FI
2 years of FI
3 years of FI

P

Abbreviations: FI, food insecurity
1
Adjusted for MMSE scores at baseline
2
Adjusted for age, years of education, MMSE scores at baseline, race/ethnicity, sex, income, household
size, obesity, hyperglycemia, hypertension, depressive symptoms, liver fibrosis, and HIV/HCV infection
3
Food insecure (low and very low food security) vs. food secure (full and marginal food security)
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CHAPTER V: ASSOCIATION OF FOOD INSECURITY WITH IMMUNE
ACTIVATION
Abstract
Background: Persistent immune activation is a hallmark of HIV infection and thought to
play a role on chronic diseases in people living with HIV (PLWH). Food insecurity is
disproportionately prevalent in PLWH and is associated with adverse health outcomes.
We determined whether food insecurity was associated with increased immune activation
in PLWH.
Methods: Plasma levels of sCD14, sCD27, and sCD163 were quantified in 323 PLWH
on antiretroviral therapy from the Miami Adult Studies on HIV (MASH) Cohort. The
U.S. Household Food Security Survey was used to assess food insecurity; defined as
marginal, low, or very low food security. Dietary intakes were assessed with 24-hour
recalls.
Results: Nearly half of participants were food insecure (42.7%) and most (85.5%) had
suppressed HIV viral loads (<200 copies/mL). Food insecurity was independently
associated with higher levels of sCD14 and sCD27. The severity of food insecurity
directly correlated with sCD14 (rho=0.151; p=0.006) and sCD27 (rho=0.154; p=0.006),
and showed a tendency to modify the relationship between CD4 cell count and sCD163
(F=2.35, p=0.07). Very low food security was significantly associated with increased
sCD163 levels among those with lower CD4 cell count (B=0.534, SE=0.22, t=2.40,
p=0.02).
Conclusions: Food insecurity may promote immune activation in PLWH, suggesting a
biological link between food insecurity and chronic disease among PLWH. Improving
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financial security and access to high-quality foods could reduce the high burden of
disease in this highly vulnerable population. Future research should consider diet quality
and gut-permeability as potential mediators of food insecurity and immune activation.

Introduction
Infection with the human immunodeficiency virus (HIV) results in chronic immune
activation and progressive immunodeficiency.1,2 Modern antiretroviral therapy (ART) has
been effective at controlling viral replication and improving longevity and quality of life
for people living with HIV (PLWH).3,4 Nonetheless, persistent immune activation and
inflammation, even with virologic suppression,5,6 contribute to high rates of chronic
comorbidities among PLWH, such as cardiovascular disease, type 2 diabetes, liver
disease, and non-AIDS-defining cancers.7-15 Consequently, non-AIDS-defining illnesses
have become the predominant causes of morbidity and mortality among PLWH in
settings where ART is readily available.16-18 Moreover, PLWH suffer from higher rates of
multi-morbidities than the general population.19,20
In addition to the immune response to HIV infection, many social and lifestyle
factors, such as sedentary lifestyle, poor diet quality, and substance abuse, can contribute
to inflammation and chronic diseases in PLWH. Food insecurity (FI) is a social
determinant of health that refers to a lack of dependable access to nutritious foods,
resulting in dependence on low-cost foods and poor quality diets.21-25 In the United
States, approximately 10.5% of the population experienced food insecurity at some point
during 2019, with significantly higher rates among minority-headed households and those
with incomes below 185% of the federal poverty line.26 Food insecurity also
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disproportionately affects PLWH in both high- and low-resource settings27 and has been
associated with several adverse health outcomes in the general U.S. population28-34 and
PLWH.35-38 There are several nutrition-related consequences of HIV infection, including
increased metabolic demands and altered gastrointestinal absorptive function. Food
insecurity further increases the risk for compromised nutritional status (e.g. malnutrition,
micronutrient deficiencies).39
Studies using data from the National Health and Nutrition Examination Survey
(NHANES) have established associations of food insecurity with pro-inflammatory diets
40

and elevated C-reactive protein (CRP).41,42 Recently, the Women’s Interagency HIV

Study (WIHS) has associated food insecurity with elevated levels of pro-inflammatory
cytokines interleukin (IL)-6 and tumor necrosis factor receptor 1 (TNFR1),43 as well as
T-cell activation (%CD38+HLADR+) in women living with HIV.44 These studies point
to biological mechanisms between food insecurity and chronic disease. However, more
studies are needed to investigate the association between food insecurity and immune
activation − a precursor to chronic disease − in PLWH. Therefore, we aimed to determine
whether food insecurity was associated with increased monocyte/macrophage (sCD14
and sCD163) and lymphocyte (sCD27) activation in PLWH.

Methods
Data from 325 participants from the Miami Adult Studies on HIV (MASH) Cohort
were cross-sectionally analyzed for this study. Eligibility in the MASH cohort includes
age of 40 years or older, documented HIV and hepatitis C virus (HCV) status (positive or
negative), and seronegative for hepatitis B virus. All participants provided written
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informed consent for participation in the study and release of medical information.
Participants who were HIV-uninfected, HCV-infected, or not taking ART were excluded
from this analysis. The protocols for the study were approved by the Institutional Review
Board at Florida International University.
Primary outcomes: Biomarkers of immune activation
Plasma levels of sCD14, sCD27, and sCD163 were quantified by analyte-specific
bead-based Luminex Multiplex immunoassays (EMD Millipore Corporations). Soluble
CD14 (sCD14) is shed by CD14-expressing monocytes after stimulation by
lipopolysaccharide (LPS, also known as endotoxin).45 Consequently, sCD14 serves as a
marker of monocyte activation, as well as an indirect, yet non-specific marker of
microbial translocation.45,46 Elevated levels of sCD14 and sCD163 persist during
effective suppressive ART and correlate with HIV disease progression.45,47,48 Shedding of
sCD163 in plasma has also been implicated in chronic inflammatory conditions.49,50
Soluble CD27 is secreted by antigen-stimulated T-cells, thus considered a direct marker
of early-stage T-cell activation. Levels of sCD27 are responsive to ART but remain
elevated in HIV infection, correlate with HIV disease progression, and have been
particularly associated with AIDS-associated lymphoma.5,51-54
Food insecurity
The USDA’s Household Food Security Survey was used to assess food
insecurity.26 The 18-item instrument determines food security through questions related
to conditions and behaviors that characterize food insecure households. Similar to
others,35,43,44 we defined food insecurity as having marginal, low, or very low food
security, whereas participants with full food security were considered food-secure.
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Diet recalls
Twenty four-hour dietary recalls were collected by trained research staff using the
Multiple Pass Method.55 The participants were provided with visual aids to improve the
accuracy of data. Dietary analysis was conducted via NutriBase Pro software, Version 17.
Copyright © 1986-2020 Cybersoft Inc. Intakes of total energy, energy from protein,
carbohydrates, and fats, and grams of saturated fatty acids (SFAs) and fiber were
considered potential confounders.
Additional covariates
Sociodemographic data were self-reported. As both food insecurity and immune
activation are associated with several chronic conditions, we incorporated several
covariates as potential confounders for the relationship between food insecurity and
immune activation. HIV viral load and CD4 cell count were obtained from participants’
medical records. Participants were considered virally suppressed if HIV RNA was below
200 copies/mL. Height, weight, vital signs, and fasting blood were obtained for all
participants. Body mass index (BMI) was calculated and reported as 5 kg/m2 increments
for more clinically relevant interpretation. Hyperglycemia (fasting plasma glucose ≥100
mg/dL), hypertriglyceridemia (TG ≥150 mg/dL), and hypertension (≥130 mm Hg systolic
or ≥85 mm Hg diastolic blood pressure) were determined. Liver fibrosis was assessed
with the Fibrosis-4 Index (FIB-4) ≥1.45, calculated from age, platelets, and serum liver
enzymes. Systemic inflammation was measured with high-sensitivity C-reactive protein
(hs-CRP). Substance use, including cocaine, cannabis, and heroin, was self-reported and
confirmed with urine toxicology (American Bio Medica, Kinderhook, NY). Cigarette
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smoking was self-reported and hazardous drinking was assessed with the Alcohol Use
Disorders Identification Test (AUDIT), using a cutoff of 8.56
Statistical analysis
The data analysis for this paper was performed using SAS software, Version 9.4 of
the SAS System for Windows. Copyright © 2002-2012 SAS Institute Inc. The data were
analyzed for outliers and assumptions of normality. Descriptive statistics were reported as
No. (%) and mean ± standard deviation (or median [interquartile range, IQR] if not
normally distributed). Participants were grouped as food-secure and food-insecure
(dichotomous), or by levels of food security (4 levels, multicategorical). Group
differences were tested with Chi-square tests, T-tests, and one-way ANOVA; due to
skewed distributions for sCD14, sCD27, and sCD163, Wilcoxon rank-sum and KruskalWallis tests were performed. Due to the direction of the hypotheses (i.e., food insecurity
is associated with higher levels of immune activation), one-sided p-values were reported
for Wilcoxon rank-sum tests. Spearman correlations were used to determine the
relationships between markers of immune activation and levels of food insecurity. To
assess the relationship between food insecurity and immune activation, linear regressions
were performed using log-transformed values of the primary outcomes. Potential
confounders were explored with linear regressions, including sociodemographic
characteristics (e.g., age, sex, race/ethnicity, income, and household size), HIV viral load
and CD4 cell count, metabolic and comorbid parameters, substance use, and dietary
intake. Parameters that were Statistical significance was set at an alpha level of 0.05 and
two-sided p-values are reported unless otherwise specified.
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Results
Characteristics
Sample characteristics are shown in Table 5.1. Of the 323 participants in the study,
185 (57.3%) were food secure and 138 (42.7%) were food insecure, with 53 (16.4%), 43
(13.3%), and 42 (13.0%) participants reporting marginal, low, and very low food
security, respectively. The participants had a mean age of 53.3±7.8 years, and were
predominantly male (n=197, 61.0%) and Black non-Hispanic (n=207, 64.1%) or White
Hispanic (n=65, 20.1%). Most households had between 1 and 2 members, with a mean
annual income of $13,315 and 73.1% (n=233) fell below the federal poverty level
(https://aspe.hhs.gov/2020-poverty-guidelines). Most participants had a maximum
education of high-school or less (n=226, 70.0%) and were disabled (n=205, 63.5%) or
unemployed (n=84, 26.0%).
Only 47 (14.5%) participants did not have suppressed HIV viral loads. The mean
CD4 cell count was 602±333 cells/µL, with only 23 (7.1%) participants who had CD4
cell count below 200 cells/µL (indicative of AIDS). The mean BMI was 29.2±6.1 kg/m2,
with 126 (39.0%) of participants classifying as obese, and mean energy intake was
1,967±1,150 kcals. Additionally, 79 (24.5%) had hyperglycemia, 99 (30.7%) had
elevated triglycerides, and 162 (50.2%) had hypertension.
Associations with food insecurity
Very low food security was associated with non-suppressed HIV viral load
(p=0.02) but not CD4 cell count (p=0.9); data not shown. Food insecurity was associated
with a higher percent of total energy intake from fats compared to food security
(37.3±10.2 vs. 34.5±12.3%; p=0.04). Neither BMI nor total energy intake differed
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between the two groups. No other significant differences in characteristics were observed
between food secure and insecure participants, although trends for lower age and lower
incomes, as well as higher hs-CRP, hazardous drinking, and use of cannabis were noted
among food insecure participants (p<0.1).
Distribution of immune activation biomarkers
Table 5.2 shows the median values of sCD14, sCD27, and sCD163. Food
insecurity was associated with higher levels of sCD14 (one-sided p=0.005) and sCD27
(one-sided p=0.003), but not sCD163 (one-sided p=0.3), compared to food security.
When examining the markers of immune activation by levels of food insecurity,
borderline differences for sCD14 (p=0.05) and sCD27 (p=0.051) were noted. The lowest
levels of sCD14 and sCD27 were found among participants with full food security.
Additionally, having a non-suppressed HIV viral load was associated with higher levels
of sCD14 (one-sided p=0.009), sCD27 (one-sided p<0.0001), and sCD163 (one-sided
p=0.032).
The severity of food insecurity was directly correlated with sCD14 (rho=0.151;
p=0.006) and sCD27 (rho=0.154; p=0.005), but not with sCD163 (rho=0.039; p=0.5);
shown in Table 5.3.
Factors associated with immune activation
We performed univariate linear regressions on log-transformed sCD14, sCD27, and
sCD163 to determine potential confounders for the relationship between food insecurity
and markers of immune activation (Table 5.4). Older age, race/ethnicity, higher BMI,
hypertriglyceridemia, hypertension, higher hs-CRP, and liver fibrosis were also
associated with markers of immune activation. Higher CD4 cell counts were associated
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with lower sCD27 levels. Trends were observed with cigarette smoking and cocaine use.
Dietary intakes of total energy, macronutrients, SFAs, and fiber were not associated with
any of the outcomes.
In multiple regressions (Table 5.5), food insecurity remained significantly
associated with sCD14 and sCD27 after adjustment for confounders. While food
insecurity and CD4 cell counts were not independently associated with sCD163 levels,
the severity of food insecurity showed a tendency to moderate the relationship between
CD4 cell count and sCD163 (F=2.35, p=0.07). As shown in Table 5.6, compared to full
food security, VLFS was significantly associated with increased sCD163 levels when
adjusted for the interaction with CD4 cell count (B=0.534, SE=0.22, t=2.40, p=0.02).
CD4 cell counts were inversely associated with sCD163 levels only among participants
with VLFS (B=-0.086, SE=0.03, t=-2.60, p=0.01).

Discussion
Food insecurity is a social determinant of health that disproportionately affects U.S.
minorities26 and PLWH27 and is associated with several chronic conditions and mortality
among U.S. adults.28-34 In this study, we show a direct association between food
insecurity and immune activation, which is thought to play a key role in HIV disease
progression, as well as the development and progression of chronic conditions.7-15 More
specifically, food insecurity was independently associated with increased plasma levels
of sCD14 and sCD27, which were also directly correlated with the severity of food
insecurity. Our findings suggest that the severity of food insecurity could moderate the
relationship between CD4 cell count and sCD163; together, VLFS and low CD4 cell
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count predicted higher sCD163 levels. The research presented herein was conducted with
PLWH from the MASH Cohort, a vulnerable population that is largely comprised of
socioeconomically disadvantaged Black and Hispanic adults who are engaged in HIV
care and virally suppressed. At least some level of food insecurity was reported by nearly
half of the participants (43%). We also found higher markers of immune activation in
association with HIV viremia, lower CD4 cell count, older age, race/ethnicity, higher
BMI, hypertriglyceridemia, hypertension, higher hs-CRP, and liver fibrosis. Our findings,
therefore, provide insights into a potential link between food insecurity and adverse
health outcomes among low-income PLWH who are on suppressive ART.
Notably, the association between food insecurity and sCD14 suggests increased
microbial translocation − a major pathway of immune activation in PLWH.57 The
Western diet, characterized by high intakes of meats, refined grains, and added sugars,
has also been associated with higher sCD14 concentrations.58 In turn, elevated sCD14 has
been associated with several chronic conditions, including cardiovascular disease,59-61
chronic kidney disease,62 alcoholic and nonalcoholic liver disease,63-67 dementia,68 HIVassociated neurocognitive disorders,69 and mortality in PLWH.70,71
Food insecurity may affect gut integrity by altering microbiome composition. The
poor-quality diets associated with food insecurity may lead to alterations in the diversity
of gut microbiota and loss of mucosal barrier defenses, resulting in increased gut
permeability, microbial translocation, and metabolic endotoxemia.72-75 High-fat diets, in
particular, have been shown to alter gut microbiota and disrupt the intestinal barrier,
inducing systemic inflammation.74,76 Indeed, in a study of 149 PLWH and 69 uninfected
controls, intakes of SFAs and added sugars were associated with intestinal fatty acid
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binding protein (I-FABP), a marker of intestinal barrier dysfunction that also correlated
with sCD163 and LPS.77 Similarly, among HIV-infected women, consuming 3 servings
of high-fat foods per day was associated with higher IL-6.43 While we did not find
significant relationships between diet and immune activation, food-insecure participants
had higher intakes of fat than food-secure participants. Additionally, more than half of
participants (53%) consumed over 10% of total energy from saturated fats, exceeding
current recommendations.78 On the other hand, fiber plays an important role in
maintaining gut integrity, as certain undigested carbohydrates are metabolized by gut
microbes producing beneficial short-chain fatty acids (SCFAs).79-81 Food insecurity in the
United States is characterized by diets that are high in refined carbohydrates and simple
sugars, thus low in fermentable fibers.21,24 We did not find a significant difference in fiber
intake between food secure and insecure participants; yet, fiber intakes in these
participants of the MASH cohort (mean 13.2±10.7 g) were well-below the
recommendations for adults over 50 years of age (22.4 g for females and 28 g for
males).78
The association between food insecurity and sCD27 may have other implications.
CD27 is a transmembrane glycoprotein belonging to the tumor necrosis factor receptor
(TNF-R) family. Although the immunological function of sCD27 has not been fully
elucidated, circulating sCD27 induces immunoglobulin G (IgG) production82 and is
highly implicated in autoimmune diseases and lymphomas,83,84 including AIDSassociated lymphoma.51,52 Thus, our findings may reflect an increased risk for cancer in
association with food insecurity, which is consistent with previous observations.85 With
regards to sCD163, we found that VLFS was associated with increased levels of sCD163
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once we accounted for an interaction effect between the severity of food insecurity and
CD4 cell count. The results therefore suggest that the severity of food insecurity may
moderate the relationship between immune activation and immunodeficiency in PLWH.
Interestingly, VLFS was associated with not having a suppressed viral load, but not with
CD4 cell count. Nonetheless, lower CD4 cell count significantly predicted higher
sCD163 levels in participants with VLFS, which could be in part explained by poor
engagement in treatment.35,86 Elevated sCD163 persists in PLWH despite suppressive
ART unless treated early in the infection47,48 and has been associated with mortality.87
Additionally, elevated sCD163 has been highly associated with states of chronic
inflammation, such as obesity,88 cardiovascular risk,89 type 2 diabetes,90 the metabolic
syndrome,91 and nonalcoholic fatty liver disease.67
The findings in this report are consistent with previous research. Population-based
studies have established an association between food insecurity and CRP, a marker of
systemic inflammation.41,42 Notably, Gowda et al. showed that the relationship between
food insecurity and CRP was partially mediated by elevated white blood cell counts,
suggesting a potential role of immune activation.41 Recently, data from the WIHS cohort
has shown that food insecurity was associated with elevated inflammation (IL-6 and
TNFR1),43 as well as CD4+ and CD8+ activation (%CD38+HLADR+) and other markers
of immune dysregulation in women living with HIV who were mostly virally
suppressed.44 These results, as well as the ones reported herein, point to biological
pathways between food insecurity and chronic disease. For example, among 121 Latinos
with type 2 diabetes, increased stress (cortisol) and inflammation (CRP) partially
mediated the relationship between food insecurity and insulin resistance, the precursor for
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type 2 diabetes.92 In another study, food insecurity was associated with the primary
allostatic system (neuroendocrine and inflammatory), which incorporated serum cortisol
and CRP as biomarkers of stress and inflammation, respectively.93 While our data did not
show an association between food insecurity and hs-CRP, hs-CRP correlated with sCD14
and showed a trend with sCD27.
Diet quality may explain some of the relationship between food insecurity,
immune-activation and inflammation, and chronic disease. Indeed, food insecurity often
leads to dependence on low-cost foods, resulting in poor-quality diets that are high in
fats, simple sugars, and refined carbohydrates, but low in essential nutrients and fiber.21-25
Micronutrients play critical roles in immunity and their deficiency can contribute to
immune activation and inflammation.94,95 Moreover, Bergmans et al. reported on the
association between food insecurity and inflammatory potential of the diet, showing a
dose-response relationship between the severity of food insecurity and the Dietary
Inflammatory Index scores.40 In our study, we found that levels of sCD14 and sCD27
were directly correlated with the severity of food insecurity. One may surmise that as the
severity of food insecurity increases, so does the immuno-inflammatory potential of the
diet.
However, diet alone does not entirely explain the relationship between food
insecurity and health outcomes.33,37 Other potential mechanisms include poor disease
management,96 chronic stress,92,97 and competing financial constraints, such as having to
make tradeoffs between food and medication98 while having increased healthcare
expenditures.99,100 Food insecurity is additionally associated with high rates of alcohol
and substance abuse,101-106 which may also contribute to poor health. Indeed, we observed
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trends between cigarette smoking and sCD27 levels, as well as between cocaine use and
sCD14 levels. Both smoking and cocaine have been associated with immune activation in
PLWH.107-109 For example, use of stimulants (cocaine and methamphetamine) was
associated with increased plasma levels of neopterin − a marker of immune activation −
among ART-treated PLWH.109 We found a higher prevalence of hazardous drinking
among food insecure participants; however, hazardous drinking was not associated with
immune activation. Previous studies have shown contrasting results in regard to excessive
drinking and sCD14 levels in PLWH.110-112
To summarize, food insecurity was associated with increased biomarkers of
immune activation sCD14, sCD27, and sCD163 in PLWH from the MASH cohort. The
present study is strengthened by the use of validated assessments among a wellcharacterized cohort of PLWH. While we controlled for intakes of energy,
macronutrients, SFAs, and fiber, future studies may consider the impact of diet quality
and microbial translocation on the relationship between food insecurity and immune
activation. The cross-sectional design does not allow to establish causality and it is
possible that some of the effects observed may be related to unmeasured factors.
However, our findings remained consistent even after controlling for several
sociodemographic and comorbid confounders. Our findings are also consistent with prior
research. Longitudinal studies may provide a more thorough understanding of the causal
and temporal relationships between food insecurity, immune activation, and chronic
disease outcomes.
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Conclusions
Food insecurity was associated with markers of immune activation in the MASH
cohort, suggesting a biological link between food insecurity and chronic disease among
PLWH. Our findings suggest that improving financial security, access to high-quality
foods, and nutrition knowledge could lead to significant health benefits in this highly
vulnerable population. Additionally, screening for food insecurity may be a cost-efficient
method of risk-assessment and reducing the high burden of disease among PLWH.
Mechanisms for the effect of food insecurity on immune activation remain to be
elucidated. Future research should consider diet quality and gut-permeability as potential
mediators of food insecurity and immune activation.
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Table 5.1. Characteristics of Study Participants

Age, years
Sex, male
Race/ethnicity
Black non-Hispanic
White non-Hispanic
White Hispanic
Multiracial/other
Household size
Annual household income ($)
Below federal poverty level
Education
Less than High-School
High-School or GED
More than High-School
Employment
Employed
Disabled
Otherwise unemployed
Metabolic
BMI (kg/m2)
Obesity
Hyperglycemia
Hypertriglyceridemia
Hypertension
hs-CRP
Substance use
Hazardous drinking
Cigarette smoking
Cocaine
Cannabis
Heroin
HIV
HIV RNA <200 copies/mL
CD4 cells/µL
CD4 <200 cells/µL
Dietary

Total
(N=323)
No. (%)
Mean ± SD
56.3 ± 7.8
197 (61.0)

Food Secure Food Insecure
(N=185)
(N=138)
No. (%)
No. (%)
P
Mean ± SD
Mean ± SD
54.0 ± 7.0
52.3 ± 8.8
.072a
113 (61.1)
84 (60.9)
.969b

207 (64.1)
20 (6.2)
65 (20.1)
31 (9.6)
1.9 ± 1.4
13,315
± 11,206
236 (73.1)

123 (66.5)
10 (5.4)
36 (19.5)
16 (8.7)
2.0 ± 1.4
14,211
± 12,515
137 (74.1)

84 (60.9)
10 (7.3)
29 (21.0)
15 (10.9)
1.8 ± 1.4
12,115
± 9,069
99 (71.7)

.724b

128 (39.6)
98 (30.3)
97 (30.0)

66 (35.7)
63 (34.1)
56 (30.3)

62 (44.9)
35 (25.4)
41 (29.7)

.159b

34 (10.5)
205 (63.5)
84 (26.0)

21 (11.4)
113 (61.1)
51 (27.6)

13 (9.4)
92 (66.7)
33 (23.9)

.584b

29.2 ± 6.1
126 (39.0)
79 (24.5)
99 (30.7)
162 (50.2)
4.9 ± 8.9

29.4 ± 6.4
74 (40.0)
49 (26.5)
58 (31.4)
94 (50.8)
4.1 ± 5.7

28.9 ± 5.7
52 (37.7)
30 (21.7)
41 (29.7)
68 (49.3)
6.0 ± 11.9

.436a
.673b
.326b
.752b
.785b
.082a

60 (18.6)
150 (46.4)
108 (33.4)
94 (29.1)
32 (9.9)

28 (15.1)
81 (43.8)
58 (31.4)
47 (25.4)
17 (9.2)

32 (23.2)
69 (50.0)
50 (36.2)
47 (34.1)
15 (10.9)

.066b
.268b
.358
.090b
.617b

276 (85.5)
602 ± 333
23 (7.1)

163 (88.1)
610 ± 322
10 (5.4)

113 (81.9)
591 ± 349
13 (9.4)

.117b
.610a
.165b
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.219a
.082a
.643b

Total energy (kcals)
Energy from protein (kcal)
% energy from protein
Energy from carbohydrate (kcal)
% energy from carbohydrate
Fiber (g)
Energy from fat (kcal)
% energy from fat
SFAs (g)
SFAs, ≥10% total energy

Total
Food Secure Food Insecure
(N=323)
(N=185)
(N=138)
No. (%)
No. (%)
No. (%)
P
Mean ± SD Mean ± SD
Mean ± SD
1967 ± 1150 1933 ± 1169
2012 ± 1125
.546a
327 ± 208
332 ± 228
321 ± 178
.653a
17.5 ± 7.0
18.0 ± 7.8
16.9 ± 5.9
.166a
925 ± 631
916 ± 629
938 ± 635
.765a
46.7 ± 13.1
47.3 ± 14.1
45.9 ± 11.8
.358a
13.6 ± 12.3
12.9 ± 11.2
14.6 ± 13.7
.246a
710 ± 485
678 ± 489
754 ± 479
.173a
35.6 ± 11.5
34.5 ± 12.3
37.3 ± 10.2
.040a
25.3 ± 21.8
24.1 ± 21.8
27.1 ± 21.8
.228
172 (53.3)
100 (54.1)
72 (52.2)
.738

Abbreviations: hs-CRP, high-sensitivity C-reactive protein; SFAs, saturated fatty acids
a
T-test
b
Chi-square test
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Table 5.2. Distribution of Markers of Immune Activation1
N
323
185
138

All participants
Food secure
Food insecurea
p-valueb

sCD14 (ng/mL)
Median (IQR)
1028.5 (801.5, 1371.9)
956.9 (731.1, 1320.2)
1115.2 (843.3, 1432.6)
0.005

sCD27 (ng/mL)
Median (IQR)
8.5 (6.2, 11.4)
8.1 (5.8, 10.5)
9.3 (6.9, 12.1)
0.003

sCD163 (ng/mL)
Median (IQR)
541.4 (349.0, 961.2)
532.8 (370.7, 874.6)
551.6 (340.9, 1046.4)
0.311

Full FS
Marginal FS
Low FS
Very low FS
p-valuec

185
53
43
42

956.9 (731.1, 1320.2)
1042.5 (837.0, 1395.8)
1117.8 (909.5, 1461.4)
1171.8 (814.7, 1437.8)
0.050

8.1 (5.8, 10.5)
9.1 (6.9, 11.5)
8.9 (6.8, 11.6)
9.6 (6.4, 13.5)
0.051

532.8 (370.7, 874.6)
517.5 (370.7, 874.6)
567.5 (310.2, 968.4)
598.7 (344.5, 1070.2)
0.745

Virally Suppressed
HIV RNA >200 copies/mL
p-valueb

276
47

997.6 (785.9, 1335.2)
1184.7 (927.6, 1522.8)
0.009

8.3 (6.0, 10.8)
10.4 (8.3, 13.7)
<.0001

535.7 (343.4, 920.7)
754.9 (379.3, 1207.7)
0.032

Abbreviations: FS, food security
a
Food insecure group includes participants with marginal, low, and very low food security. Full food
security is the reference group; b Wilcoxon rank-sum tests were performed to compare distribution of
sCD14, sCD27, and sCD163; one-sided p-values are reported; c Kruskal-Wallis omnibus test was
performed to test for differences in sCD14, sCD27, and sCD163 by levels of food security (full, marginal,
low, and very low food security). Dwass, Steel, Critchlow-Fligner method for pairwise multiple
comparisons yielded no significant differences between categories.

Table 5.3. Spearman Correlation Coefficients (Rho) Between Markers of Immune
Activation, CD4 Cell Count, and Severity of Food Insecurity (N=323)
FI severitya
sCD14 (ng/mL)
.151*
sCD27 (ng/mL)
.154*
sCD163 (ng/mL)
.039
CD4 (cells/µL)
.057
a
From least to highest severity of food insecurity: full (0), marginal (1), low (2), and very low food security
(3)
* p<0.01; ** p<0.0001
sCD27
.398**

sCD163
.271**
.301**

CD4
-.019
-.149
-.057
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Table 5.4. Univariate Regressions for (Log-Transformed) Markers of Immune Activation in The MASH Cohort
(N=323)
Parameter
Age, 5 years
Sex
Race/ethnicity

Income, $1000
Household size
Metabolic

Hepatic
Substance use

HIV
Diet

Female
White non-Hispanic
White Hispanic
Multiracial/other
BMI, 5 kg/m2
Hyperglycemia
Hypertriglyceridemia
Hypertension
Log hs-CRP
Liver fibrosisa
Hazardous drinkingb
Cigarette Smoking
Cocaine
Marijuana
Opioids
HIV RNA >200 copies/mL
CD4, 100 cells/µL
Total energy, 100 kcals
Protein energy, 100 kcals
Carbohydrate energy, 100
kcals
Fat energy, 100 kcals
SFAs, g
Fiber, g

Log sCD14 (ng/mL)
β
SE
t
p
.025
.02 1.60 .110
.095
.05 1.88 .061
.204
.10 1.96 .051
.041
.06
.65 .518
-.023
.09 -.27 .791
.001 .002 0.25 .806
.008
.02
.46 .643
.007
.02
.34 .732
-.055
.06 -.96 .340
.104
.05 1.95 .052
.083
.05 1.69 .092
.055
.02 2.62 .009
.124
.05 2.29 .023
.068
.06 1.07 .289
.042
.05
.85 .399
.101
.05 1.94 .053
.070
.05 1.29 .199
.045
.10
.45 .650
.143
.07 2.04 .042
-.003
.01 -.40 .690
.021
.02
.95 .342
.019
.01 1.54 .125

Log sCD27 (ng/mL)
β
SE
t
p
.051
.02 3.21
.002
.016
.05
.32
.750
.232
.10 2.21
.028
-.089
.06 -1.40
.163
-.118
.09 -1.37
.172
-.002 .002
-.67
.503
-.014
.02
-.78
.437
-.001
.02
-.05
.959
-.086
.06 -1.46
.145
.090
.05 1.64
.102
.129
.05 2.57
.011
.039
.02 1.81
.072
.123
.05 2.24
.026
-.041
.06
-.64
.526
.086
.05 1.71
.089
.077
.05 1.44
.151
.041
.06
.74
.458
-.027
.10
-.27
.790
.271
.07 3.87 .0001
-.020
.01 -2.75
.006
-.016
.02
-.72
.473
.012
.01 1.00
.320

.002
.005
.008
-.008
.132

-.005
-.002
.0001
-.025
.120

.004
.01
.01
.02
.05

.61
.98
.66
-.41
2.66

.544
.327
.512
.685
.008

.004
.01
.01
.02
.05

-1.31
-.34
.08
-1.21
2.38

.190
.733
.940
.226
.018

Log sCD163 (ng/mL)
β
SE
t
p
.010
.02
.39 .693
.118
.08 1.53 .127
.385
.15 2.49 .013
.320
.09 3.40 .001
.271
.13 2.13 .034
.003 .003
.77 .442
-.022
.03
-.81 .418
.093
.03 3.05 .003
.043
.09
.49 .621
.173
.08 2.13 .034
.013
.08
.17 .864
.019
.03
.59 .559
-.060
.08
-.73 .465
.122
.10 1.26 .208
-.010
.08 -1.33 .185
-.028
.08
-.35 .728
.094
.08 1.14 .257
-.242
.15 -1.63 .105
.214
.11 2.02 .044
-.010
.01
-.86 .389
.012
.03
.34 .734
.026
.02 1.41 .159
-.0005
.004
.006
.016
.022

.01
.01
.02
.03
.08

-.08
.46
.36
.52
.29

.936
.644
.718
.607
.768

Food insecurityc
Abbreviations: SFAs, saturated fatty acids
a
Fibrosis-4 Index (FIB-4) ≥1.45; b Alcohol Use Disorders Identification Test (AUDIT) ≥8; c Food insecure group includes participants with marginal,
low, and very low food security. Full food security is the reference group.
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Table 5.5. Relationship Between Food Insecurity and (Log-Transformed) Markers of Immune Activation Controlling
for Demographic, Dietary, Clinical, and Behavioral Factors (N=323)
Log sCD14 (ng/mL)
β
SE
t
p
.132 .05 2.66 .008

Log sCD27 (ng/mL)
β
SE
t
p
.120 .05 2.38 .018

Log sCD163 (ng/mL)
β
SE
t
p
.022 .08 .29 .768

2) Adjusted for sociodemographic characteristics,
HIV viral load, and CD4 cell countb

.135

.05

2.73

.007

.122

.05

2.50

.013

-.004

.07

-.06

.955

3) Additionally adjusted for dietb

.138

.05

2.65

.009

.128

.05

2.54

.012

.009

.08

.12

.907

Model
1) Food insecuritya (univariate)

4) Additionally adjusted for metabolic parameters .117 .05 2.25 .025
.129 .05 2.56 .011
.024 .08 .31 .758
and substance usec
a
Food insecure group includes participants with marginal, low, and very low food security. Full food security is the reference group.
b
Age, sex, race/ethnicity, income, household size, HIV viral load >200 copies/mL, and CD4 cell count
c
Total energy (kcals), energy from protein, carbohydrates, and fats (kcals), saturated fats (g), and fiber (g).
d
BMI, hyperglycemia, hyperlipidemia, hypertension, liver fibrosis (FIB-4 ≥1.45), high-sensitivity C-reactive protein, hazardous drinking, cigarette
smoking, cocaine, and opioids.

Table 5.6. Regression for Log-Transformed sCD163 with Food Insecurity and CD4 Cell Interaction (N=323)
Parameter
Food insecurity

CD4, 100 cells/µL

Category
Marginal FS
LFS
VLFS
Full FS

β
.037
.079
.534
Reference

SE
.22
.25
.22
-

t
.18
.32
2.40
-

p
.859
.748
.017
-

F
1.88
-

p
.115
-

.007

.02

.43

.664

1.88

.171

Food insecurity*CD4

CD4*Marginal FS
-.013 .03
-.42 .678 2.35 .072
CD4*LFS
-.001 .04
-.02 .984
CD4*VLFS
-.086 .03 -2.60 .010
CD4*Full FS
Reference
Abbreviations: FS, food security; LFS, low food security; VLFS, very low food security
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CHAPTER VI: SUMMARY AND CONCLUSIONS
The present study investigated whether food insecurity was associated with
NAFLD, cognitive impairment, and immune activation in socioeconomically
disadvantaged adults from the MASH Cohort. A summary of the hypotheses and results
can be found in Table 6.1. For the first time, this study established: 1) an association
between food insecurity and NAFLD in people living with and without HIV using direct
and highly-accurate measures of liver steatosis and fibrosis, 2) a relationship between the
frequency of food insecurity, particularly persistent food insecurity, and cognitive decline
in people living with and without HIV, and 3) an association between food insecurity and
immune activation in people living with HIV. Our findings highlight the consequences of
social disparities and the insidious impact of food insecurity, a complex socioeconomic
issue that encompasses social, behavioral, and biological factors contributing to
numerous adverse health outcomes and lower quality of life. Fortunately, food insecurity
is a modifiable risk factor, thus the results of this study may inform public health
advocacy and aid in policies targeted at reducing social disparities in access to essential
components of life, such as safe and adequate nutrition.
Both NAFLD and cognitive disorders are pressing health issues for aging
populations, particularly vulnerable groups such as PLWH. Nonalcoholic fatty liver
disease has rapidly become the most prevalent liver disease in the Western world,1
affecting almost a third of all U.S. adults.2-4 Yet, PLWH are highly vulnerable to liver
diseases and susceptible to liver disease progression and related complications.5
Cognitive impairments and dementia are seen in approximately 18-21% and 5-8%,
respectively, of U.S. adults aged 50 and older.6,7 Over half of all PLWH in the United
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States are 50 years of age and older8 and as many as half of PLWH show signs of
cognitive dysfunction,9 although more conservative estimates place the prevalence of
HAND between 14-28% of PLWH aged 50 and older.10 Persistent immune activation in
HIV infection, in addition to its role in HIV disease pathogenesis, has been implicated in
liver disease11,12 and cognitive disorders among PLWH.13 Furthermore, advanced liver
disease has also been linked to immune activation11,14 and cognitive impairments in
PLWH.15,16
Approximately a third of the MASH Cohort participants were food-insecure, a
prevalence rate that is consistent with that seen in U.S. households earning less than
185% of the federal poverty level.17 However, there was no significant difference in the
prevalence of food insecurity between PLWH and HIV-uninfected participants. Our
estimates also suggest that the prevalence of NAFLD, liver fibrosis, and advanced liver
fibrosis in the MASH Cohort were 16.1%, 15.1%, and 4.6%, respectively. Compared to
HIV-uninfected, PLWH were at increased risk for liver fibrosis, but not NAFLD or
advanced liver fibrosis. Also, at baseline, approximately 15% of participants had
cognitive impairment and PLWH who were not virally suppressed (HIV RNA > 200
copies/mL) showed a nearly 3-fold increased risk for cognitive impairment compared to
HIV-uninfected participants.
With respect to Aim 1, we used MRI-PDFF to assess liver steatosis and MRE to
assess liver fibrosis. Food insecurity was associated with greater liver fat content only
among obese participants, and we observed a significant interaction effect between BMI
and food insecurity on NAFLD. In other words, food insecurity modified the effect of
BMI on NAFLD, increasing the risk associated with increasing BMI among those who
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experienced food insecurity. Additionally, food insecurity was associated with increased
risk for any liver fibrosis (stage 1 or higher) and advanced liver fibrosis (stage 3 or
higher). The effects of food insecurity were not significantly different between PLWH
and HIV-uninfected participants. Our findings were similar to those by Golovaty et al.,
who investigated the association between food insecurity and NAFLD using NHANES
2005-2014 data and indirect indexes of liver steatosis and fibrosis.18 Unlike our
observations, Golovaty et al. found that food insecurity was independently associated
with higher odds of NAFLD, but similar to us, food insecurity was also associated with
increased risk for advanced liver fibrosis. Notably, the effect sizes in both studies were
similar.
For Aim 2, we assessed cognitive impairment at baseline and at 2-year follow-up
with the MMSE (cutoff of ≤ 24). Our results showed that (1) VLFS was associated with
cognitive impairment at baseline, (2) baseline food insecurity was associated with
cognitive impairment after a 2-year follow-up, and (3) the frequency of food insecurity
over the 2-year period was associated with cognitive decline, (4) particularly when it was
persistent. On the other hand, the risk for cognitive impairment associated with food
insecurity was not significantly different between PLWH and HIV-uninfected
participants. The findings support what has been previously reported by Wong et al., who
found that food insecurity at baseline was associated with cognitive impairment at 2-year
follow-up and the greatest impact was seen in association with VLFS.19 However,
Hobkirk et al. found that food insecurity was associated with cognitive deficits in PLWH
but not HIV-uninfected participants using a neurocognitive battery.20 The contrasting
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results may be related to poor sensitivity of the MMSE in our study and the small sample
of HIV-uninfected participants in the Hobkirk study.
Lastly, for Aim 3, we used plasma sCD14, sCD27, and sCD163 as biomarkers of
immune activation among HIV-infected participants. Food insecurity was associated with
greater immune activation in PLWH, as determined by higher levels of (log-transformed)
sCD14 and sCD27. The severity of food insecurity was directly correlated with sCD14
and sCD27 levels. The severity of food insecurity also appeared to moderate the
relationship between CD4 cell count and sCD163 (p=0.07). Indeed, VLFS was
significantly associated with increased sCD163 levels among those with lower CD4 cell
counts. While this is the first report on food insecurity and immune activation, the
findings are consistent with prior studies that have associated food insecurity with
markers of systemic inflammation.21-23 The association between food insecurity and
sCD14 also suggests increased microbial translocation − a major pathway of immune
activation in HIV infection.24
The results presented herein add to a growing body of evidence on the adverse
effects of food insecurity on health outcomes among vulnerable populations. Although
the prevalence of food insecurity in the United States has declined after the aftermath of
the Great Recession,25 it remains now at levels similar to those in the late 1990’s.17
Furthermore, the prevalence of food insecurity remains disproportionately elevated
among minorities and other marginalized groups.17 The burden of food insecurity is
particularly worrisome among PLWH, for whom it may have added risks due to the
compromising nature of the HIV infection. Notably, food insecurity was not associated
with increased effects for PLWH compared to HIV-uninfected participants. Nonetheless,
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due to the high prevalence of food insecurity among PLWH, our findings suggest that
food insecurity might substantially contribute to the increased burden of morbidity
among PLWH. Importantly, food insecurity was associated with immune activation in
PLWH, in whom persistent immune activation and inflammation, despite effective ART,
contribute to adverse health outcomes, such as HIV disease progression and ageassociated chronic comorbidities. The results of this study are therefore highly relevant to
U.S adults living with HIV, in whom poverty and food insecurity, along with other social
disparities, are highly and pervasively prevalent. Public health strategies to mitigate food
insecurity among PLWH are warranted.
It is important to recognize that the results of this study are necessarily not
applicable to the general population, as food insecurity predominantly affects low-income
households, particularly minority headed-households.17 This study does, however,
characterizes a highly vulnerable subset of the population with high rates of poverty, food
insecurity, chronic diseases, and mental health problems, including depression and
substance use disorders. The MASH cohort represents those who have the greatest need
for improved public health efforts to diminish social disparities, including the insidious
food insecurity that contributes to poorer health outcomes.
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Table 6.1. Summary of Hypotheses and Findings
No.

Hypothesis

Results

1a

FI will be associated with increased risk for
NAFLD (liver fat >5%) as determined by MR
imaging-derived proton density fat fraction
(MRI-PDFF).

FI was associated with greater liver fat content only among obese participants (4.8±2.0 vs.
3.8±1.9%; P=0.03).
There was a significant interaction effect between FI and BMI on the risk for NAFLD
(P<0.0001). For every 5-unit increase in BMI, the odds of NAFLD were 3.83 (95% CI:
2.37−6.19; P<0.0001) times higher in food-insecure participants compared to 1.32 (95% CI:
1.04−1.67; P=0.02) times higher in food-secure participants.

1b

FI will be associated with increased risk for
liver fibrosis as determined by magnetic
resonance elastography (MRE).

FI was associated with increased risk for liver fibrosis (OR:1.65, 95% CI: 1.01−2.72; p=0.048)
and advanced liver fibrosis (OR: 2.82, 95% CI: 1.22−6.54; p=0.02), adjusted for confounders.

1c

The effects of FI on liver outcomes will be
significantly higher in PLWH than HIVuninfected participants.

There were no significant interaction effects between FI and HIV infection.

2a

FI will be independently associated with
increased risk for cognitive impairment as
determined by the Mini-Mental State
Examination (MMSE).

VLFS was associated with cognitive impairment at baseline (OR: 4.16, 95% CI: 1.28−13.55;
p=0.02).
Baseline FI was associated with cognitive impairment after a 2-year follow-up (OR: 4.21,
95% CI: 1.66−10.68; p=0.002).

2b

The risk for cognitive impairment will
correlate with the frequency of FI.

The frequency of FI over the 2-year period was associated with cognitive decline (OR: 1.85
per year of food insecurity, 95% CI: 1.23, 2.77; p=0.003), particularly when it was persistent
(OR: 6.77, 95% CI: 1.72−26.68; p=0.006).

2c

The relationship between FI and cognitive
impairment will be stronger among PLWH
than HIV-uninfected participants.

There were no significant interaction effects between FI and HIV infection.

3a

FI will be associated with increased immune
activation in PLWH as determined by plasma
levels of sCD14, sCD27, and sCD163.

FI was associated with higher levels of (log-transformed) sCD14 (β=0.13, SE=0.05; p=0.008)
and sCD27 (β=0.12, SE=0.05; p=0.018). FI also showed a tendency to moderate the
relationship between CD4 and sCD163 (F=2.35, p=0.07) − VLFS was associated with
increased sCD163 levels among those with lower CD4 counts (B=0.53, SE=0.22; p=0.02).

The severity of FI will correlate with levels of The severity of food insecurity was directly correlated with sCD14 (rho=0.15; p=0.006) and
sCD14, sCD27, and sCD163.
sCD27 (rho=0.15; p=0.006) levels.
Abbreviations: FI, food insecurity; VLFS, very low food security
3b
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CHAPTER VII: STRENGTHS AND LIMITATIONS
Population
The present study was conducted in a well-characterized cohort of predominantly
low-income, minority, middle-aged and older adults living with and without HIV. The
homogeneity of sociodemographic characteristics among cohort participants is a strength
of the study. Moreover, the prevalence of food insecurity in the MASH Cohort is
remarkably similar to what is seen among low-income U.S. households.1 That said,
young adults and White non-Hispanics are underrepresented in the MASH Cohort. With
respect to PLWH in the MASH Cohort, the vast majority are engaged in care, receiving
ART, and virally suppressed, and are therefore similar to those enrolled in the Ryan
White Program2 and other U.S. cohorts of PLWH in care,3 but it may not represent all
PLWH in the United States4 An additional benefit of this study being conducted with the
MASH Cohort is that it allows for longitudinal follow-up to expand on our findings.
Assessments
The study is further strengthened by the use of highly validated assessments. The
U.S. Household Food Security Survey (HFSS) is the most widely utilized and wellvalidated assessment of food insecurity.5 The HFSS assesses a respondent’s perceived
food sufficiency and adequacy, food-related anxiety, and instances of hunger that
occurred in the household during the past 12 months. Yet, the HFSS does not capture the
entire gamut of elements that comprise food insecurity, trading off comprehensiveness
for simplicity and comparability.5 The use of MRI-PDFF and MRE, in particular,
provides a high level of accuracy compared to other non-invasive liver assessments.6 On
the other hand, 354 MASH Cohort participants were ineligible for the magnetic
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resonance liver scans, which may have led to sampling bias. The frequency of food
insecurity, however, did not differ between those eligible and ineligible for liver scans.
The MMSE is the most widely used and well-studied screening assessment for
neurocognitive disorders7 and has shown high accuracy for the detection of dementia.8
Yet, screening tools are generally insufficiently sensitive to mild and HIV-related
cognitive disorders. That said, our findings indicate that food insecurity may be a
clinically relevant risk factor for severe cognitive impairment. We also used widely
studied plasma biomarkers of immune activation, allowing for comparisons across other
cohorts.
Covariates
We performed multivariable analyses to account for several potential confounders
of the associations between food insecurity and study outcomes, including
sociodemographic characteristics (age, sex, race/ethnicity, income, education, and
household size), metabolic factors (e.g., BMI, hyperglycemia, hypertension), mood
(depressive symptoms), and substance use. While these analyses confirmed the
associations and strengthened the results, there may be unmeasured confounders that
were unaccounted for. Our analyses on NAFLD are presumptive of no excess alcohol
consumption, but this was self-reported, thus, subject to underreporting. This is also no
different from what is done in other clinical and research settings. It is also possible that
some of the effect of food insecurity on liver fibrosis seen in this study may not be
metabolic- or NAFLD-related; however, the association with advanced liver fibrosis was
significant while controlling for and excluding HCV infection.
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Design
Most of our analyses employed a cross-sectional design, which does not allow for
temporality to be established. As a result, we cannot conclude that food insecurity
precedes liver disease and immune activation. For example, HIV/HCV infection may
result in liver fibrosis and lead to psychosocial factors, such as poverty and drug use, that
contribute to food insecurity. Factors associated with immune activation, such as fragility
and increased morbidity, may contribute to food insecurity by decreasing functional
capability and work opportunities.
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CHAPTER VIII: FUTURE RESEARCH
The findings, as well as the limitations of this study indicate that further research is
warranted. Potential mechanisms and mediators for the effects of food insecurity reported
in this study should be examined, including dietary patterns and diet quality, negative
coping behaviors, and chronic stress. Moreover, all of the outcomes examined in this
study are inter-related. Future studies could consider these interrelationships and examine
the direct and indirect effect of these variables. For instance, does elevated immune
activation mediate the relationship between food insecurity and cognitive decline?
Longitudinal studies are needed to establish whether food insecurity precedes liver
disease and immune activation. Longitudinal analyses could help elucidate the long-term
effects of food insecurity, including its severity, frequency, and persistence, on the
progression of liver disease and cognitive decline. Additionally, such studies may also
indicate whether the trajectory of outcomes over time differs between PLWH and HIVuninfected persons.
Although liver assessments by magnetic resonance have the advantage of increased
accuracy, they restrict the sample to only those participants who are eligible for the scans.
Future studies could incorporate additional non-invasive assessments of liver disease,
compare diagnostic accuracy, and examine how food insecurity relates to the different
measures. Based on our findings, other designs including comprehensive neurocognitive
batteries would improve on this research via improved diagnostic accuracy, sensitivity to
mild cognitive impairments, and elucidation of the specific cognitive domains affected by
food insecurity. Neuroimaging studies can identify specific brain structures altered by
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food insecurity. Furthermore, further research on immune activation should incorporate
additional markers of inflammation and microbial translocation.
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